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Abstract 
Enzymes increase the rate at which chemical reactions occur. How they achieve this rate increase 
has been an area of intense research for many years. Multiple studies have shown that dynamic 
motions of individual protein segments can play a role in enzyme function. Our enzyme of 
interest, phosphoenolpyruvate carboxykinase (PEPCK), has multiple dynamic motions that work 
in concert during the catalytic cycle. One of these mobile elements, termed the Ω-loop due to its 
architecture, acts like a lid that closes over the active site and has been hypothesized to serve 
multiple functions during the catalytic cycle. Furthermore, the act of opening and closing the lid 
domain is thought to be a delicate free energy balance, meaning the lid pays an energetic penalty 
to close, which is offset by the energetic contribution from substrate binding. To investigate the 
role of the loop, specifically the open/closed transition, and to probe for unappreciated roles, 
multiple mutant enzymes were created. In the first set of mutations the lid region was removed to 
investigate other potential roles for the Ω-loop. In the second set two different amino acid 
residues (Ala-467 and Glu-89) were mutated to either increase the energetic penalty of lid 
closure or decrease the energetic contribution from substrate binding. The resultant mutants were 
characterized via structure/function experiments. The data revealed two new roles for the Ω-loop 
lid, confirmed the delicate free energy balance, and shed light on the energetic pathway between 
the active site and the lid. Taking into account the data from the WT and all seven mutant 
PEPCK enzymes, a revised model for the role of the Ω-loop lid during catalysis is proposed: The 
role of the lid during the catalytic cycle is to correctly position the substrates in the active site, 
stabilize the R-loop and N/C-terminal lobe closure, and sequester and protect the reaction 
intermediate. 
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Chapter 1 . Introduction to phosphoenolpyruvate carboxykinase and enzyme 
dynamics 
Phosphoenolpyruvate carboxykinase, hereafter referred to as PEPCK, catalyzes the 
decarboxylation of oxaloacetate (OAA) with subsequent phosphorylation to form 
phosphoenolpyruvate (PEP), utilizing a triphosphate nucleotide as the phosphoryl donor. Drs. 
Merton Utter and Kiyoshi Kurahashi discovered PEPCK in 1954 while they were investigating 
CO2 fixation in heterotrophic bacteria (1). Since that time the enzyme has been isolated and 
studied from a multitude of species, including yeast, Escherichia coli (E. coli), plants, rodents, 
and humans.  
Isozymes of PEPCK 
From the first characterization by Utter and Kurahashi it was realized that PEPCK requires a 
nucleotide (ATP or GTP) for enzymatic activity (1). The ATP-dependent PEPCK is found in E. 
coli, yeast, C4 plants, and other bacteria, while GTP-dependent PEPCK is found in all higher 
eukaryotes, e.g. rodents, birds, mammals (2, 3). The GTP-dependent class of PEPCK can further 
be divided into two isoforms, cytosolic PEPCK (cPEPCK) and mitochondrial PEPCK 
(mPEPCK), so named for their final intracellular locations (1, 4). The percent of activity of each 
isoform, specifically in the liver, is variable and species-dependent: humans have a 50-50 split of 
the two isoforms, rats and mice have 90-95% cytosolic, and chickens have 100% mitochondrial 
(Table 1-1) (2, 3). A comparison of the ATP and GTP classes of PEPCK reveals that, despite 
sharing very little sequence homology, the overall structural topology is highly similar 
(backbone RMSD) with all active site residues and architecture conserved (Appendix 1) (5). 
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Table 1-1. Ratio of cytosolic vs. mitochondrial PEPCK isoforms.  
The relative distribution of each isoform in the liver of various animals was determined by 
assaying the enzyme activity in both the cytosol and the mitochondria in the livers of the species 
listed below. It is assumed that this distribution will be found in the other tissues that express 
PEPCK (a select few tissues have been tested and this assumption holds true). Adapted from 
Croniger, et al. (6).  
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The Gene  
The genes for the cPEPCK and mPEPCK isoforms in humans are located on two different 
chromosomes, #14 and #20 respectively, with each gene containing ten exons and nine introns 
(7, 8). The two genes differ in the size of their introns, which results in the mitochondrial gene 
being 9000 base pairs while the cytosolic gene is only 5500 base pairs (9). Although mPEPCK is 
synthesized as a 640 amino acid protein, upon translocation into the mitochondrial matrix the 32 
amino acid leader sequence is cleaved, resulting in the active form being 608 amino acids. This 
final size is comparable to cPEPCK at 622 amino acids. In their mature forms they have a 
sequence identity of 71%.  
Expression and Regulation of PEPCK 
The current knowledge about the enzyme PEPCK has been largely derived from studies carried 
out on rodents. For this reason what is known in detail, about the expression and regulation, is 
limited to the cytosolic isoform of PEPCK (10). Cytosolic PEPCK is expressed in liver, the 
major organ for gluconeogenesis, but it has also been found in other tissues such as the kidney, 
white/brown adipose tissue, muscle, brain, and mammary gland (6). Beginning with early work 
on PEPCK, it was recognized that diet and hormones very precisely regulate the transcription 
and translation of the enzyme. Expression of PEPCK is induced by glucagon (via cAMP), 
glucocorticoids (except adipose tissue), and in the kidney via a pH change (reviewed in (11)). 
PEPCK expression is down regulated by insulin, pH changes (in the kidney), and glucocorticoids 
(adipose tissue only) (11). Recently it was discovered that PEPCK has a post-translational 
mechanism of regulation via lysine acetylation (12-14). As mentioned above, the information on 
mPEPCK is very limited, but what has been learned is that mPEPCK is constitutively expressed 
in multiple tissues and has a half-life of 60 hours; this is significantly different from cPEPCK, 
which is tightly regulated and has a half-life of only eight hours (6). 
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Metabolic Role of PEPCK 
The biological role of PEPCK in metabolism has been extensively studied. PEPCK is often 
broadly defined as a cataplerotic enzyme, meaning it removes TCA cycle anions for usage in 
downstream pathways. More specifically, it has been shown to play an active role in glucose 
homeostasis, triglyceride biosynthesis, and serine synthesis (Figure 1-1) (reviewed in (9)). 
PEPCK participates in glucose homeostasis by catalyzing the first committed step of the 
gluconeogenesis pathway. This role for PEPCK explains its presence in the liver and kidney, the 
two major gluconeogenic tissues. However, a role in gluconeogenesis does not explain the 
enzyme’s presence in non-gluconeogenic tissues, such as white and brown adipose tissue, 
muscle, brain, and small intestine (15). The presence of PEPCK in white and brown adipose 
tissue has been investigated, the evidence data suggests PEPCK is active in glyceroneogenesis, 
which supplies glyceride-glycerol for triglyceride production (16, 17). While the role of cPEPCK 
has been well characterized in liver, kidney, and adipose tissue, the presence of PEPCK in other 
tissues and the impact of mPEPCK on metabolism is still unclear.  
 5 
 
Figure 1-1. Metabolic pathways of PEPCK. 
The biosynthetic pathways in which the PEPCK reaction products are utilized are shown in (a) 
gluconeogenesis, (b) glyceroneogenesis, (c) serine synthesis, and (d) the recycling/oxidation 
pathway. Adapted from Yang et al. (9) 
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PEPCK Catalysis 
GTP-dependent PEPCK (E.C. 4.1.1.32) is a functional monomer that has a molecular mass of 
~70 kilo-daltons and an absolute requirement of two divalent cations for activity. Multiple 
studies have been carried out which determined that Mn
2+
 is the most activating cation for GTP-
dependent PEPCKs (18-20). Additionally, a second divalent cation is required for reactivity, 
binding in the active site in the form of a metal-nucleotide substrate complex. The mechanism by 
which the PEPCK reaction proceeds has been investigated extensively. However, there is still no 
consensus on the order in which substrates bind to the enzyme. This has led to the conclusion 
that it has a random binding mechanism (reviewed in (21)). There is clear evidence that the 
chemistry proceeds via a step-wise process in which OAA is decarboxylated, forming an enolate 
intermediate, followed by the transfer of the γ-phosphate from GTP to the enolate, forming the 
products PEP, GDP, and CO2 (Figure 1-2). The PEPCK reaction is freely reversible, but has 
been shown to proceed only in the OAA to PEP direction in vivo. As an exception to this 
observation, Ascari Suum, a parasitic nematode, utilizes PEPCK as an anaplerotic enzyme to 
refill the TCA cycle by fixing CO2 and synthesizing OAA from PEP (22).  
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Figure 1-2. Mechanism of PEPCK catalysis 
The reaction catalyzed by PEPCK is the decarboxylation of OAA to form the highly reactive 
enolate intermediate followed by the concomitant transfer of the γ-phosphate from GTP to form 
PEP, GDP, and CO2. All structural and biochemical evidence points towards the reaction 
proceeding through a highly reactive enolate intermediate step.  
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Structural Characteristics of PEPCK 
For the first 40 years of research on PEPCK, all work was carried out utilizing biochemical 
assays to determine mechanistic properties of the enzyme. In 1996 the first crystal structure was 
solved of ATP-dependent PEPCK from E. coli, allowing the enzyme to be viewed at the 
molecular level for the first time (23). A few years later the structure of both the mitochondrial 
PEPCK from chicken and the cytosolic PEPCK from rat were solved. These structures revealed 
extensive details on how the GTP-dependent enzyme catalyzes the conversion of OAA to PEP 
(24, 25). The ATP-PEPCK structural work revealed that PEPCK consists of two globular 
domains, an N- and C-terminal domain, with the active site in a cleft between the domains 
(Figure 1-3). One point that must be stressed is that these domains do not fold independently of 
one another; rather the polypeptide backbone makes multiple passes between the domains. The 
basic information that is taken from a global look at PEPCK is that the overall fold of the 
enzyme groups it into the P-loop containing, nucleoside-triphosphate-hydrolase fold and 
superfamily (23). 
Nucleotide specificity- As mentioned previously, PEPCK is classified by the nucleotide that it 
utilizes, ATP or GTP. The structural information revealed a number of features that have evolved 
to allow nucleotide selectivity (5). Recall that the purine ring of guanosine and adenosine differ 
at the 2- and 6-positions (Figure 1-4). At the C-2 position GTP has an amino group that 
crystallographic evidence demonstrated interacts with a phenylalanine (PDB ID: 2QEY); ATP 
lacks this amino group (25). This difference is not believed to be the reason for the difference in 
specificity, due to the fact that GTP-PEPCKs utilize inosine nucleotides (which also lack the C-2 
amino group) with similar kinetic efficiency as their guanosine counterparts. The other position 
on the purine ring that is different between guanosine and adenosine is the C-6 position; in GTP 
and ITP this is a carbonyl, while ATP has an amino group. The difference at this position on the 
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purine ring is thought to contribute to the nucleotide specificity, due to the fact that in the 
PEPCK–Mn
2+
–Mn
2+
GTP structure the C-6 carbonyl functions as a hydrogen bond acceptor, 
interacting with the backbone amide of a phenylalanine and the side chain amide nitrogen of an 
asparagine (Figure 1-5) (25). Obviously, the amino group of ATP does not function as a 
hydrogen bond acceptor, and therefore, cannot make these interactions. Further studies are 
needed to completely establish the mechanism of nucleotide specificity.  
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Figure 1-3. Structure of WT PEPCK with Mn
2+
.  
A global view of PEPCK. The M1 manganese atom is shown in red, α-helices in blue, and β-
sheets in cyan. 
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Figure 1-4. Relevant nucleotide triphosphates. 
ATP, GTP, and ITP differ at their C2 and C6 positions. Structural studies have revealed that 
higher eukaryotes utilize GTP and ITP over the ATP nucleotide due to differences at the C6 
position of the purine ring.   
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Figure 1-5. GTP binding site 
GTP binds to PEPCK through a number of direct interactions that are shown by the dashed lines. 
The purine ring has pi stacking interactions with the multiple aromatic side chains of 
phenylalanine, and the γ-phosphate of GTP interacts with the M1 and M2 manganese ions 
(interactions not shown). The distances of the different interactions are (a) 2.87Å (b) 2.77 Å (c) 
2.92 Å (d) 3.37 Å (e) 3.80 Å (f) 2.94 Å (g) 2.78 Å (h) 3.50 Å (PDB ID: 2QEY). 
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Dynamic Elements- Currently there are over 40 different structures of PEPCK isozymes in the 
protein data bank (PDB) solved with various small molecules (appendix 2). A number of 
structures that are deposited were part of a series of experiments designed to map out the reaction 
coordinate. This was accomplished by crystallizing PEPCK in multiple complexes to analyze 
structural changes that occur as the enzyme binds the different ligands (24-27). A comparison of 
these structures has identified multiple movements that occur during the catalytic cycle. There 
are four major loops or regions that display conformational flexibility that need to be 
highlighted: 1) the 10-residue Ω-loop lid, 2) the P-loop, 3) the R-loop, and 4) the bi-lobal motion 
of the enzyme (Figure 1-6a). The Ω-loop is a highly mobile region on the protein surface that 
shifts between an open and closed conformation depending upon the ligands bound in the active 
site (27). The P-loop or kinase-1a motif shows similar mobile behavior, changing its 
conformation with substrate binding (25). The P-loop cradles the nucleotide, aiding in its 
positioning. In addition, the P-loop contains a reactive cysteine residue whose modification 
results in inactivation of the enzyme and a lysine residue that aids in the leaving group ability of 
the γ-phosphate (28-30). The R-loop is the third mobile element. This loop contains an arginine 
residue (R87) that binds directly to the ligand in the OAA/PEP binding site through electrostatic 
interactions. Unlike the previous two mobile loops, this loop does not have a 0.5 Å or larger 
movement associated with it. However, crystallographic evidence (compare B-factors in PDB 
ID: 2QEW, 2QEY and 2RK7) revealed that this loop undergoes an ordered (holo) to disordered 
(GTP bound) to ordered (oxalate bound) transition, dependent upon the ligand bound. These 
transitions suggest a role for this loop in allowing or preventing lid closure. The last major 
motion is imparted by the bi-lobal nature of PEPCK. As previously mentioned, PEPCK folds 
into two interdependent domains with the active site in a cleft between the two domains or lobes. 
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When the structures of PEPCK–Mn
2+
 (PDB ID: 2QEW) and PEPCK–Mn
2+
–Ox–Mn
2+
GTP (PDB 
ID: 3DT2) are superposed, the N-terminal lobes overlay precisely while the C-terminal lobes are 
offset by ~3Å (Figure 1-6b). This led us to hypothesize that as the enzyme progresses through 
the catalytic cycle, it has a clam-shell type motion that decreases the size of the active site cleft, 
effectively repositioning the phosphate donor and acceptor to facilitate PEPCK’s enzymatic 
activity.  
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Figure 1-6. Mobile elements of PEPCK.  
PEPCK has multiple mobile domains that have been identified via X-ray crystallography. (A) The Ω-loop 
lid (red) has been shown to change its conformation from open/disordered to closed/ordered upon 
substrate binding. The P-loop (yellow) cradles the GTP nucleotide shifting it forward by ~0.5Å to 
correctly position it for phosphoryl transfer. The R-loop (green), which contains arginine 87 (essential for 
OAA/PEP binding), has been observed in either an ordered or disordered state dependent upon the 
substrates in the active site. (B) The last motion associated with PEPCK is the bi-lobal motion in which 
the N and C-terminal lobes transition from open (green: PEPCK–Mn
2+
) to closed (blue: PEPCK–oxalate–
Mn
2+
–Mn
2+
GTP) upon substrate binding to constrict access to the active site by bulk solvent.  
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Enzyme Dynamics  
Enzymes have evolved to efficiently catalyze chemical reactions, but understanding how they 
operate has been an area of extensive research for decades. It is widely accepted that enzymes 
achieve their significant catalytic power by their unique ability to decrease the free energy or 
transition state barrier of a chemical reaction (Figure 1-7a). However, how an enzyme lowers the 
barrier has been an area of extreme debate, with multiple hypotheses proposed over the years 
(reviewed in (31)). One of the more recent ideas put forth is enzyme dynamics, more 
specifically, it was proposed that all motions on the protein surface can alter the free energy 
profile of the enzyme and aid in transition state crossing. This contribution of dynamics to 
catalytic power has been questioned based upon experimental evidence of the time scales at 
which reactions and motions occur (summarized in (32)). To summarize, large-scale motions 
such as whole domain movements occur on the millisecond (ms) to second time scale, loop 
movements function on the nanosecond (ns) to microsecond (μs) time scale, and side chain 
rotamers occur on the picosecond (ps) to nanosecond (ns) time scale (Figure 1-7b) (32). While 
all of these motions are extremely fast they are still orders of magnitude slower than the amount 
of time it takes for bond vibration to occur, on the femtosecond (fs) time scale. The fact that 
dynamic motions are probably too slow to be directly involved in transition state crossing does 
not mean that these motions are not vital to the catalytic properties of an enzyme. The crossing of 
the transition state barrier is just one step in the catalytic cycle and the steps leading up to and 
after this event are of equal importance. In the case of PEPCK, crystallographic studies have 
revealed multiple motions (loops, rotamers, and whole domains) that undoubtedly act in concert 
in order for chemistry to occur.  
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Figure 1-7. Free energy of chemical reactions and time scales of protein motions 
In order for a chemical reaction to occur it must overcome the free energy barrier preventing 
bond breakage. In solution two substrates will eventually overcome this barrier; however, in a 
biological setting, the reaction must occur significantly faster so that life can exist. To overcome 
the free energy barrier quickly, nature has evolved to utilize enzymes to lower the barrier (A). 
How enzymes reduce this barrier is an area of extensive debate. What is known is that enzymes 
have mobile elements that contribute to their activity and these motions operate within a very 
narrow time regime (B). Adapted from Henzler-Wildman (32)  
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PEPCK dynamic motions during catalysis 
As mentioned above the PEPCK reaction steps were deduced from a series of protein crystal 
structures. This structural series revealed multiple regions undergoing conformational changes at 
different times during the catalytic cycle. The structural work also gave detailed insight into the 
binding of both the nucleotide and ligands and how the interactions are connected to the mobile 
elements of the protein.  
Substrate Binding- The first step in any enzyme catalyzed reaction is the binding of substrates in 
the active site. The crystallographic structure of PEPCK–Mn
2+
–OAA (PDB ID: 2QF1) 
demonstrates that OAA binds to the enzyme by directly coordinating to the M1 manganese ion, 
which is absolutely required for PEPCK activity (Figure 1-8) (25). In addition to the interactions 
between OAA and the M1 Mn
2+
 ion, binding of OAA is facilitated by interactions with the side 
chains of Arg-87 and Ser-286 (Figure 1-8) (25). The structure of PEPCK–Mn
2+
–Mn
2+
GTP (PDB 
ID: 2QEY) shows that GTP binds to PEPCK within the unique nucleotide-binding site of GTP-
dependent PEPCKs. This results in multiple interactions between the enzyme and both the 
guanosine ring and the phosphoryl groups (Figure 1-5) (25). One such interaction involves Lys-
290, located in the P-loop, bridging the β- and γ-phosphoryl groups. This interaction, along with 
coordination of the γ-phosphate between the M1 and M2 metal ions, facilitates the ability of the 
γ-phosphate to act as a leaving group (5). Comparing the two structures (2QF1 and 2QEY) 
reveals that the Ω-loop lid is in an open/disordered orientation in both complexes, the R-loop is 
disordered when OAA is not bound, and lastly but most importantly, the substrates are not 
positioned close enough for catalysis to occur (5).  
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Figure 1-8. OAA binding site. 
OAA binds to PEPCK through interactions with the M1 manganese ion (gray sphere), Arg-87, 
and Ser-286. The distance of each interaction is as follows: (a) 2.82Å (b) 3.54 Å (c) 3.39 Å (d) 
2.28 Å (e) 2.26 Å. 
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Formation of the Michaelis Complex- After formation of one of the single substrate complexes, 
PEPCK binds the second ligand, forming the lid-open Michaelis complex (Figure 1-9A). This 
complex has OAA and GTP positioned for a direct in-line phosphoryl transfer, but at a distance 
that is too great for nucleophilic attack (5). To bring the substrates closer, the next step in the 
catalyzed reaction is the sampling of the lid-closed conformation by the Ω-loop (Figure 1-9B). In 
order for the Ω-loop lid open/closed transition to occur, certain motions must act in concert to 
remove a potential steric clash between Thr-465 in the Ω-loop and Ala-287 in the P-loop (5). 
The P-loop cradles the nucleotide and has to close/move by ~0.5 Å to remove the clash and 
allow the Ω-loop to close. The P-loop movement simultaneously repositions the GTP molecule 
towards OAA and the M1 metal, shortening the distance to allow in-line phosphoryl transfer (5). 
The second major motion that must occur is the closure of the N- and C-terminal lobes to reduce 
the size of the active site cleft and exclude solvent. Following closure of the P-loop and the 
inward movement of the N- and C-terminal lobes can the Ω-loop sample the closed 
conformation. Experimental evidence clearly demonstrates that each of these motions is essential 
for catalysis (5).  
Chemistry- After forming the lid-closed Michaelis complex, the substrates are positioned for 
PEPCK catalysis. Based upon the structural information, residues Asn-403 and Arg-87 facilitate 
the decarboxylation of OAA forming the enolate intermediate. These two residues flank both 
sides of the carboxylate of OAA, causing polarization of this substrate and ultimately the CO2 
leaving group propensity (Figure 1-9-C) (25). Additionally, Tyr-235 rotates forward to interact 
with and stabilize the CO2 product. This rotation forward by Tyr-235, to aid in stabilization, is 
not observed in the complexes with OAA (compare Figure 1-9-B & C) (27). The transfer of the 
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γ-phosphate to the resultant enolate occurs by positioning and stabilizing the phosphoryl group 
through electrostatic interactions with Arg-405, Lys-290, and the M1 and M2 metal ions (5). 
Lid Opening and Product Release- Once the products PEP, GDP, and CO2 are formed, the 
enzyme reverses the process described above, starting with the sampling of the lid open 
conformation (Figure 1-9-D & E). Upon sampling of the lid open state, the N- and C-terminal 
lobes open and Tyr-235 shifts to its rearward orientation, which allows for the release of the CO2 
(27). Next, the PEP product shifts away from direct coordination to the M1 and M2 metal ions 
into outer-sphere coordination, in which it interacts with the M1 metal, Arg-87, and Arg-405 
(27).  Once PEP shifts to outer-sphere coordination, the stabilizing interactions it made with the 
P-loop are removed, allowing for P-loop opening. This opening results in the shift of the GDP 
nucleotide away from the M1 metal. The combination of the shift by Tyr-235 to a rearward 
orientation, the shift of PEP to outer-sphere coordination, and the opening of the P-loop and Ω-
loop allows for product release and ultimately the transition back to the beginning of the catalytic 
cycle (5).  
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Figure 1-9. Structural look at the chemical reaction of PEPCK. 
The substrates, products, and mobile elements are colored by molecule: M1 and M2 manganese 
ions (tan), GTP/GDP (magenta), OAA (burgundy), oxalate (green), CO2 (cyan), PEP (blue), Ω-
loop (yellow), P-loop (red), and the R-loop (black). The amino acid residues involved in 
substrate binding interactions are rendered as gray ball-and-stick models colored by atom type 
and labeled. Panels A and B are WT PEPCK–OAA–Mn
2+
–Mn
2+
GTP with 2 molecules (A and 
B). Panel C is WT PEPCK–enolate–Mn
2+
–Mn
2+
GTP. Panels D and E are WT PEPCK–PEP–
Mn
2+
–Mn
2+
GDP with 2 molecules (A and B). In panel E the green spheres around the M1 metal 
are water molecules. Dashed lines represent substrate-protein interactions.  
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A Free Energy Landscape model for PEPCK catalysis 
During protein synthesis, most proteins adapt a stable 3-dimensional fold, meaning an enzyme is 
rigid enough to maintain an overall structure, but flexible enough to allow substrate binding, 
chemical reaction, and product release (33). The driving force behind correct protein folding is 
the ability of the protein to adapt the lowest energy state or reach the bottom of the folding 
funnel (34). Once an enzyme has reached this final folded state, any dynamic elements on the 
protein surface will continue to sample multiple conformations until the relevant catalytic 
complex is formed (33, 35). However, the conformations sampled are dictated by the global free 
energy profile of the enzyme, as random sampling will hamper catalytic efficiency (35). Rather, 
the enzyme samples a select few conformations that are optimized for substrate binding (35). In 
the case of PEPCK all of the substrates bind to the lid open form of the enzyme (27). Upon 
binding, in a clear example of a classical induced-fit mechanism, the enzyme adapts a 
catalytically active conformation by altering the orientations of multiple mobile elements (27). It 
is only upon closure of these loops and domains that the substrates are positioned correctly to 
allow for catalysis to proceed (27). Furthermore, the structural data support a model in which the 
free energy profile for the enzyme is modified as ligands bind during progression through the 
catalytic cycle (Figure 1-10 A-C) (5). This model was developed by observing structures of 
PEPCK in complex with different substrates (OAA, PEP, GTP, and GDP). In these complexes, 
the mobile regions, specifically the Ω-loop lid, were always in an open conformation (Figure 1-
10-A) (25). When the structure of the Michaelis complex was solved, there was a 50-50 
distribution of lid states between open and closed (Figure 1-10-B) (27). Finally, the structure 
with the enolate intermediate bound always has the lid in the closed conformation (Figure 1-10-
C) (27). These data suggest that the formation of the closed-lid state is increasingly favored as 
the enzyme progresses from the holo enzyme through the Michaelis and intermediate complexes. 
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This operates by a mechanism in which the entropic penalty of closing the lid is offset by the 
favorable Gibbs free energy of interaction between enzyme and ligands, building on the idea put 
forth by Fersht and Jencks (36, 37). To summarize, a portion of the enthalpic energy of binding 
is partitioned to the protein, offsetting an unfavorable entropic change that results from the lid 
assuming an ordered closed conformation rather than a conformationally dynamic open state.  
Combining all of the structural and biochemical data on PEPCK has led to a proposed model for 
the role of the Ω-loop lid domain in catalysis. In this model, the Ω-loop is energetically coupled 
to ligand binding. The data further suggested a number of functional roles for the lid domain 
(27), the first being the correct positioning of the substrates, which only occurs upon the closure 
of the P-loop and Ω-loop domains (5). The other roles of the lid deal with the reaction 
intermediate, the enolate. Since the enolate is highly reactive, the chemical mechanism 
necessitates its protection from bulk solvent. Exposure of the enolate to water would result in its 
protonation resulting in the formation of pyruvate, a deleterious alternative chemistry (27). It is 
proposed that closure of the Ω-loop sequesters the enolate in the active site and protects the 
reaction until phosphoryl transfer can occur (38). Through the finely tuned dynamic motions, and 
particularly the motion of the lid element, PEPCK can catalyze the conversion of OAA to PEP.  
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Figure 1-10. Free energy distribution of lid conformations 
A cartoon representation of the free energy diagram for the conformational shift between the lid 
open and closed states in the (A) holo enzyme, (B) Michaelis complex, and (C) the enolate 
intermediate. 
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Chapter 2 Removal of the Ω-loop lid domain 
Introduction  
Enzymes catalyze a multitude of different chemical reactions. Understanding how they function 
has been an area of interest for many years. It is commonly accepted that proteins are not rigid in 
solution, but flexible and able to sample multiple conformations to adapt a catalytically active 
form (33). The ability to sample different conformations can vary widely between enzymes, 
meaning the mobile elements can theoretically be as small as a side chain rotameric shift, as 
large as a whole domain shift, or complete structural refolding. There are multiple different 
regular secondary structures that a protein region can fold into (α-helix, β-sheet, etc.) and these 
can have motional properties as well. One non-regular secondary structure element is an omega-
loop which is a 10-20 amino acid region characterized by its resemblance to the Greek letter 
omega with a very narrow end-to-end distance (3-5 Å typically) (39). This type of loop is usually 
on the protein surface and can have a conformational movement of up to 10 Å at the tip (40). 
These different conformations are usually observed via X-ray crystallographic analysis when 
different substrates are bound to the enzyme. The open/closed transition can be ligand gated and 
is often essential for catalysis (27, 40). One enzyme that has been structurally characterized and 
found to have a catalytically important Ω-loop is PEPCK (24, 25, 27). 
PEPCK catalyzes the first committed step of the gluconeogenesis pathway, the reversible 
decarboxylation and phosphorylation of OAA to form PEP (Figure 1-2). The reaction is freely 
reversible in vitro, but operates primarily in the direction of PEP synthesis in vivo. PEPCK 
requires two divalent cations for enzymatic activity, with the preferential cations being Mn
2+
 and 
Mg
2+
 (18-20). Manganese is the most activating cation in the GTP-dependent isoforms of 
PEPCK, but Mg
2+
 presumably fills the second cationic site, since the metal-nucleotide complex 
is the true substrate, there is more Mg
2+
 present than Mn
2+
, and the nucleotide has a higher 
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affinity for Mg
2+
. PEPCK has been extensively characterized biochemically and, more recently, 
structurally. The structural studies illustrated many previously unappreciated features of PEPCK, 
specifically the different mobile elements the Ω-loop lid, the P-loop, the R-loop and the bi-lobal 
fold (Figure 1-6 a/b) (reviewed in (5)). These features were identified by mapping the protein as 
it progressed through the catalytic cycle, utilizing substrate analogs to mimic the different 
complexes (27). As the enzyme transitions from the holo state to the Michaelis complex to the 
intermediate state, each mobile element moves in concert with the others to play their individual 
roles culminating in catalysis. The R-loop and the P-loop are involved in OAA and GTP binding, 
respectively. Further, the bi-lobal fold and the Ω-loop lid transition between an open/closed 
conformation without directly interacting with the substrates in the active site. However, in order 
for the Ω-loop and the bi-lobal motions to occur, the P-loop must first move forward by ~0.5 Å 
(5). This movement serves two purposes: one to remove the steric clash between Thr-465 on the 
Ω-loop and Ala-287 on the P-loop, and too, correctly position the γ-phosphate of GTP for direct 
inline phosphoryl transfer (5). As soon as the P-loop has repositioned the GTP, and OAA is 
bound, the N- and C-terminal lobes can sample the closed conformation, which effectively 
reduces the size of the active site, helping to protect the highly reactive enolate intermediate 
formed during the transition from OAA to PEP. Once the lobes have closed, the Ω-loop adapts 
the closed conformation, forming a stable salt bridge between His-470 on the lid and Glu-89 on 
the R-loop (Figure 3-1) (25). The structural data suggest that only upon closure of the Ω-loop are 
all substrates correctly positioned for catalysis to proceed. Furthermore, based on the step-wise 
reaction scheme for PEPCK and its progression through the highly reactive enolate another role 
for the Ω-loop is in the protection and sequestering of the enolate from alternative chemistries 
(5). 
 28 
Multiple other enzymes, such as triosephosphate isomerase, glutathione synthetase, and ribulose-
1,5-bisphosphate carboxylase/oxygenase, have also been shown to have an Ω-loop that 
transitions between an open and closed conformation (40-43). Based on the structural work on 
these enzymes, a role was proposed for the Ω-loop (similar to PEPCK) in which the loop acts to 
sequester and protect the reaction intermediate; however, after removal of the loop and 
subsequent functional assessment, additional roles for the Ω-loop were discovered, such as 
recruiting of charged groups to the active site, aiding in correctly positioning substrates and side 
chains, and stabilizing protein conformations (40-42). The realization that the structural 
information tightly constrained the role of the Ω-loop in these other enzymes and that only upon 
loop removal were the other functional roles elucidated, leads to the idea that in PEPCK the Ω-
loop potentially has further roles during the catalytic cycle than currently recognized.  
To investigate the proposed role of the Ω-loop lid in PEPCK catalysis and elucidate any further 
roles for it, a series of lid deletions were created (Figure 2-1). The loop in PEPCK is 11 amino 
acids starting at residue 464 and ending at 474. The distance between the Cα of Ala-464 and Val-
474 is ~5 Å; knowing the normal Cα-Cα bond distance to be ~4.5 Å, it was hypothesized that it 
would take between 1-3 amino acids to successfully bridge the gap without distorting the overall 
fold and the region immediately before and after the Ω-loop. Three lid deletion mutants were 
created, each of which removed residues 464-474 and replaced them with one glycine (Ld_1g), 
two glycines (Ld_2g), or three glycine residues (Ld_3g). In order to elucidate further roles of the 
lid domain in PEPCK function the mutants were characterized via structural and thermodynamic 
techniques to further investigate the role of the active site lid.  
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Figure 2-1. Lid deletion amino acid sequence 
Amino acid sequence of WT and Ld_1, 2, 3g PEPCK with the site of the mutation in bold and 
underlined. The Ω-loop amino acid sequence is italicized. 
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Results  
Kinetic characterization of the lid deletion mutations 
Kinetic experiments (Assays A-D see chapter 5 kinetic assays) were attempted for all three lid 
deletion mutants. However, due to the removal of the Ω-loop, the mutant enzymes were unable 
to catalyze the conversion of OAA to PEP, or vice versa, at a detectable rate. Furthermore, the 
mutant enzymes were unable to catalyze the first half-reaction (Assay C), the decarboxylation of 
OAA.  
Nucleotide binding by fluorescence quenching.  
Direct measurements of the KD values for IDP and ITP were carried out by intrinsic protein 
fluorescence quenching. The inosine nucleotides were substituted in place of guanosine to reduce 
the inner filter effect observed when guanosine nucleotides are utilized, inosine absorbs less of 
the excitation energy than guanosine. PEPCK utilizes inosine and guanosine nucleotides with 
similar catalytic efficiency, while ITC experiments on the human enzyme have demonstrated the 
exocyclic C-2 amino group of guanosine nucleotides increases the affinity of the enzyme for 
those nucleotides by approximately an order of magnitude over that of the inosine analogue (44). 
As shown in Table 2-1, WT PEPCK has a KD for ITP of 0.79 µM while Ld_1g has a KD of 4.7 
µM, Ld_2g has a KD of 2.4, and Ld_3g has a KD of 3.2. Meanwhile, the dissociation constants 
for IDP are 2.7 µM, 40 µM, 16 µM, and 32 µM for WT and Ld_1, 2, and 3g respectively. The 
curve fits of the raw data can be found in Appendix 3. 
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Table 2-1. Thermodynamic binding constants of lid deletion PEPCK 
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Structural characterization of lid deletion mutants 
The removal of the Ω-loop and replacement with one, two, or three glycine residues left the 
mutant enzymes catalytically inactive. In order to determine the cause of the inactivity and 
investigate any additional roles for the Ω-loop lid, the structure of each lid deletion was solved in 
complex with βSP, PEP, or oxalate, plus either GTP or GDP, and Mn
2+
. Data statistics can be 
found in Appendix four. The lack of enzymatic activity made it possible to utilize the 
physiological substrate PEP in place of its analog PGA (used in the WT studies). OAA could 
have been used in place of βSP, however, the non-enzymatic decarboxylation of OAA in the 
presence of metal would have caused a mixture of OAA and pyruvate in the active site. 
Assuming, the electron density maps were of sufficient resolution it would not be an issue to 
model in both substrates, but for the sake of clearly identifying what is affected by the lid 
removal, the OAA analog (βSP) was utilized. Structural studies on the WT enzyme in complex 
with βSP, PGA, and oxalate demonstrated that as the enzyme commits to catalysis the 
thermodynamic favorability of the enzyme adapting the closed lid conformation increases (27). 
In order for the enzyme to properly orient the active site for catalysis, a series of structural 
changes must occur. These motions include the closing of the P-loop, ordering of the R-loop, 
closing of the N- and C-terminal lobes, and the closing of the Ω-loop lid (5). A disruption of any 
of these motions will hamper catalysis (28, 29, 38). Crystals of each lid deletion were grown 
under similar conditions as previously used for the WT enzyme; however, the removal of the lid 
allowed the enzymes to pack in a different crystal lattice. The crystals had a different 
morphology upon inspection, which resulted in a different Bravais Lattice when indexing the 
diffraction data. The WT PEPCK co-crystallized with GTP/GDP and soaked with the substrate 
analog are observed to be in the P21 space group, while the lid deletion mutants grown identically 
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are in P212121. The higher order space group is indicative of tighter packing and allows the data 
to be collected using a 90° wedge, as opposed to collecting a full 360° in the P21 crystals.  
The structures of the lid deletion mutants in each individual complex were highly similar, 
allowing generalizations to be drawn for each structural complex. The first is the Michaelis 
complex in the physiological OAAPEP reaction. In each of the mutant isoforms βSP and GTP 
are bound in the active site in an identical orientation observed in the lid open molecule of the 
WT enzyme of the same complex (for an example see Figure 1-9). There are no significant 
differences between the mutants and WT in this complex except the absence of the Ω-loop (there 
are no significant distortions of the regions before and after the lid) (Figure 2-2). In the Michaelis 
complex in the PEPOAA reaction, PEP-GDP, a comparison between the WT and the mutants 
reveals no differences among the different mobile elements. The only difference observed is that 
in the mutants there is a mixture of GDP and GTP in the active site. HPLC purified GDP was 
utilized in the crystallization conditions, but a small contamination of the solution with GTP 
remains. The binding constants for the di- and tri-phosphates (Table 2-1) show a slightly higher 
affinity for the tri-phosphate, which could account for the mixture of the two in the active site. 
As a result of the contamination the PEP molecule has a slightly reduced occupancy of its 
phosphate, but it does bind in an identical orientation to that observed in the WT PEPCK-PEP-
Mn
2+
 complex (PDB ID: 2QZY).  
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Figure 2-2. Active site lid region of Ld_1, 2, and 3g. 
Upon lid removal the protein still adapts its native fold with no distortion around either hinge 
region (464 or 474). Each panel is a different lid deletion mutant in complex with βSP (tan) and 
GTP (magenta) A) Ld_1g, B) Ld_2g, C) Ld_3g. The small yellow loop is the glycine residues 
which replaced 464-474. The blue Ω-loop that is visible is from the WT enzyme in the same 
complex to show where the lid would normally reside.  
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The last set of structures solved for the lid deletion mutants were those obtained in complex with 
oxalate and GTP. In this complex with the WT enzyme all of the mobile elements are 
closed/ordered (R-loop, P-loop, Ω-loop, and the N/C terminal lobes) and Y235 is rotated forward 
aiding in the stabilization of the CO2 leaving group and through it the enolate intermediate (See 
Figure 1-9). In the lid deletions the R-loop is observed in two conformations (Figure 2-3). The 
first orientation is normal compared to the WT enzyme, but the second is flipped out. The flipped 
conformation, with a minor occupancy less than 30%, results in a displacement of residues 86-89 
with the Cα of R87 being moved the furthest at 6Å. The P-loop is occupying the rearward 
orientation, which in turn keeps GTP at a non-catalytically relevant distance from the enolate 
intermediate. This sampling is true for the N- and C-terminal lobes as well. A detailed look 
through the peptide backbone reveals positive difference density which could account for the 
shift in the lobes from open to closed, but the predominant orientation of the lobes is in the open 
conformation. The other interesting feature of the lid deletion complexes with oxalate and GTP 
is the split conformation of Y235. As shown in Figure 1-9 in the WT enzyme Y235 rotates 
forward to aid in stabilizing the CO2 leaving group upon decarboxylation of OAA. In these 
mutants Y235 has a 50-50 occupancy of the forward and rearward orientations. Combining all of 
the structural data and keeping in mind the inactivity of the lid deletion mutants, additional roles 
for the Ω-loop can be proposed.  
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Figure 2-3. R-loop movement in Ld_3g 
The lid deletion mutants in complex with GTP showed a minor occupancy for a “flipped” out 
orientation (green) with arginine 87 no longer positioned to interact with the enolate 
intermediate. The Ω-loop is yellow, P-loop is red, GTP is magenta, oxalate is green, manganese 
is coral, and the normal orientation for the R-loop is black.   
 37 
Discussion 
Structural characterization of proteins via X-ray crystallography and NMR has allowed scientists 
to visualize the protein surface at the molecular level. This has led to the observation that 
primary, secondary, and tertiary structural elements each have a certain inherent flexibility 
allowing them to sample multiple conformations (33, 35). One non-regular secondary structural 
element that has been observed in multiple enzyme systems to have mobile features that are 
critical to catalytic function is the omega-loop (Ω-loop) (41, 42, 45-51). This particular type of 
loop is characterized by its very narrow end-to-end distance, resulting in the structural domain, 
resembling the Greek letter omega (Figure 2-4). A number of enzymes with this type of loop 
undergo a transition from disordered to ordered as the enzyme binds substrates for catalysis (39, 
40, 42, 47). This ligand gated transition is usually identified by crystallographic analysis when 
different substrates are bound to the enzyme (24, 27, 39). Utilization of crystallography limits the 
enzyme to the lowest energy state for a given enzyme-substrate complex, therefore, the 
involvement of the Ω-loop in catalysis is generalized by what is observed in the electron density 
for these WT structures. Previous studies carried out on the glycolytic enzyme triosephosphate 
isomerase, glutathione synthetase, and ribulose-1,5-bisphosphate carboxylase/oxygenase 
illustrate that structural information on the WT enzyme alone does not reveal the entire role for 
an Ω-loop in catalysis (41-43). To further probe the role of the Ω-loop in each respective enzyme 
the loop was removed. Upon functional assessment it was determined that additional roles for the 
Ω-loop existed in each enzyme system.  
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Figure 2-4. Architecture of an Ω-loop 
An omega loop looks like the Greek letter Ω, shown in yellow, with a minimal distance 
separating the ends. In the case of PEPCK the end-to-end distance is 5.21Å. The other colored 
regions are the mobile P-loop (red) and R-loop (black) and the substrates GTP (magenta), 
oxalate (green), and CO2 (teal).   
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The gluconeogenic enzyme PEPCK was discovered in the 1950’s and has been extensively 
characterized metabolically and biochemically. It was only recently (15 years ago) that the first 
structure of PEPCK was solved, and only within the last five years that structural changes 
occurring during catalysis were mapped out (23-25, 27). It was from these more recent structural 
studies on PEPCK that the Ω-loop was identified. Based upon the ligand-gated nature of the Ω-
loop and the chemical mechanism of PEPCK, progressing through an enolate intermediate, a 
model for Ω-loop function was put forth (27). In the model the Ω-loop of PEPCK acts as an 
active site lid and functions to sequester and protect the reaction intermediate, correctly position 
substrates, and aid in the transition between ground states. As previous studies have shown 
characterization of a WT enzyme does not necessarily reveal the entire scope of loop 
involvement in catalysis (40, 42). In order to fully probe the role of the active site lid in PEPCK 
catalysis, the 11 amino acid Ω-loop was removed and replaced with 1-3 glycine residues.  
Rational behind lid removal 
The unique architecture of an Ω-loop results in a narrow end-to-end distance (Figure 2-4). In the 
case of PEPCK the Cα of the loop hinge residues, Ala-464 and Val-474, are ~5 Å apart. 
Therefore, replacing the 11-amino acid loop in PEPCK with one, two, or three glycine residues 
should allow the loop to be removed without distorting the overall fold of the protein. 
Furthermore, the area directly around the hinge regions should have minimal distortion, if any at 
all. The removal of the loop will result in the loss of any stabilizing interactions between the Ω-
loop and the body of the protein. The loss of stabilizing interactions will test the proposed model 
(Chapter 1. A free energy landscape model for PEPCK catalysis) for PEPCK Ω-loop function in 
substrate positioning and enolate protection, and allow additional roles to be elucidated.  
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Kinetic and thermodynamic characterization 
PEPCK catalyzes the reversible OAAPEP reaction at a reasonable rate in vitro (See Chapter 3 
Table 3-1 for WT values). However, any mutation can have a profound effect on catalysis if that 
residue is involved in the enzyme’s function. In the case of PEPCK the Ω-loop was predicted to 
play a role in the catalytic cycle by correctly positioning substrates and protecting and 
sequestering the reaction intermediate. Removal of the lid and replacement with one, two, or 
three glycines rendered the enzyme catalytically inactive in each of the four assays utilized in 
PEPCK characterization. To determine whether or not this was a result of loop removal and not a 
function of disrupted binding, fluorescence quenching experiments were performed to 
investigate nucleotide binding. The results of those experiments (Table 2-1) show that nucleotide 
binding is only slightly affected. The difference in ITP binding is 5-fold at the most (Ld_1g) but 
is still 4.7 µM, while the KD for IDP is decreased 15-fold to 40 µM in the mutant with the 
biggest change (Ld_1g). While the values do differ, the degree to which they have been altered is 
not large enough to account for the total inactivity of the lid deletion mutants. At the present time 
there is not a reliable assay in which to measure direct ligand (OAA/PEP) binding to see if it has 
been disrupted. However, the crystallographic evidence illustrates that these ligands bind to the 
enzyme in their native orientations.  
Structural characterization of ∆464-474 PEPCK 
The lack of enzymatic activity in each of the kinetic assays for the Ld_1g, 2g, and 3g mutants 
suggests that lid removal equates to loss of activity, but the question how or why the enzyme is 
inactive remains. To try and answer this question the structure of each lid deletion mutant was 
solved in complex with βSP-GTP, PEP-GDP, and oxalate-GTP. These are the same 
substrates/analogs used when WT PEPCK was structurally characterized (24, 25, 27). Through 
this series of structures it was observed that PEPCK has a number of regions undergoing 
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dynamic changes dependent upon the ligation state of the enzyme (Figure 1-6A). One of these 
mobile elements, the P-loop, contains a reactive cysteine residue (C288) that upon modification 
(WT PEPCK) results in the inactivity of the enzyme (28, 29). At the time of the inactivation 
studies, the crystal structure of PEPCK had not been solved nor had the P-loop been identified; 
however, in light of the recent structural work, the inactivity is presumably due to the prevention 
of the P-loop from moving forward in the active site. The P-loop movement is required to 
correctly position the GTP/GDP nucleotide and remove a steric clash between Thr-465 on the Ω-
loop and Ala-287 on the P-loop. PEPCK has two other motions that undergo an open/close 
transition upon ligand association, the N- and C-terminal lobes and the Ω-loop lid (Figure 1-
6A&B). The motion of the lobes was not readily identified from the original study, for the simple 
fact that the motion of the lobes is not significantly large. Superposing the WT PEPCK–Mn
2+
 
and WT PEPCK–oxalate–Mn
2+
–Mn
2+
GTP structures revealed that the N- and C-terminal lobes 
are offset from one another. Upon submission of these PDB files for normal mode analysis this 
motion was exaggerated and easily identified (Figure 1-6B) (52). The normal mode analysis 
server (El Némo) predicts possible conformations of a macromolecule in solution, or in the case 
of PEPCK the largest amplitude motion between the two different structures. What is observed 
in the crystal lattice is restrained by packing interactions between the molecules. The server is 
able to predict the freedom the enzyme would enjoy in solution and accurately predict its free 
range of motions. Although, the server is limited in its ability to predict when the motions occur, 
knowledge from the extensive crystallographic characterizations of WT PEPCK predicts that the 
lobes close upon ligand association. The last mobile element is the Ω-loop lid, which has been 
shown to change its conformation from open to closed, based on the ligation state of the enzyme 
(27). The importance of these transitions is critical to PEPCK function.  
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(i) βSP-GTP Michaelis-like complex and PEP-GDP Michaelis complex 
The first structures solved for each of the lid-deletion mutants were the forward and reverse 
Michaelis complexes. The forward Michaelis complex is formed with βSP (Figure 3-4) and 
GTP; this is the same complex used in the WT enzyme (PDB ID: 3DT7). In the WT structure 
there were two molecules in the asymmetric unit (ASU), with one molecule occupying a closed 
lid conformation and the other an open lid. All of the lid deletion mutants mimic the lid open 
complex, with all active site substrates and residues in identical orientations to their WT 
counterpart. In the reverse Michaelis complex, PEP was used instead of the substrate analog 
PGA (used in WT PDB ID: 3DTB). Due to the kinetic inactivity observed with the mutant 
enzymes, the true complex with PEP-GDP could be utilized. In the WT enzyme with PGA-GDP 
it was observed, similar to the βSP-GTP complex, to have two molecules in the ASU, with one 
adapting an open lid conformation and the other a closed lid conformation. In the Ld_1, 2, and 
3g structures the enzyme retains the lid open conformation. The biggest difference is that PEP 
binds in a different orientation compared to PGA. However, the structure of WT PEPCK has 
been solved in complex with PEP and a comparison of the orientations shows that in each of the 
lid deletions, PEP is oriented identical to the WT structure. The one unusual aspect of the PEP-
GDP complexes was in each mutant a mixture of GTP and GDP can be found in the active site. 
This mixture of the two nucleotide species is thought to be a contamination of the GDP stock by 
GTP.  
(ii) Oxalate-GTP Intermediate 
As PEPCK progresses through the reaction coordinate the enolate intermediate is the most 
important step to protect from bulk solvent. A mimic of the enolate (oxalate; Figure 3-4) is 
utilized for the structural characterization, as it has been shown to bind the active site manganese 
similar to the C1 and C2 carbons of OAA. In the WT enzyme the structure in complex with 
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oxalate and GTP is always observed in the closed lid state. To make this transition happen, a 
number of mobile elements must change conformations (Figure 1-9). In contrast, the lid deletion 
mutants in complex with oxalate and GTP are observed primarily in the open lid conformation. 
What is different from the WT enzyme is that the R-Loop has a minor conformation in which it 
is flipped out of the active site toward bulk solvent, and the N- and C-terminal lobes of the 
enzyme are open (Figure 2-5A). The differences between the structures of the WT and mutant 
enzymes suggest additional roles for the Ω-loop lid. First, the flipping out of the R-loop has 
never been observed previously, which suggests that the interaction between His-470 and Glu-
89, upon lid closure, aids in stabilizing the lid-closed conformation (suggested in (24)) and 
further stabilizes the R-loop to maintain ligand association. In the WT structures with oxalate the 
N- and C-terminal lobes are always observed to be closed. Lobe closure aids in the ability of the 
active site to exclude bulk solvent, aiding in protection of the reaction intermediate (Figure 2-
5B), and more importantly, positions the phosphoryl donor and acceptor close enough for 
phosphoryl transfer. In the lid deletion enzymes the lobes are observed to be in the open 
conformation, which suggests that lid closure acts as a latch between the lobes allowing them to 
remain closed during the chemical steps of the reaction. The results from this study allow a new 
model for Ω-loop function during PEPCK catalysis to be proposed.  The Ω-loop lid on the 
surface of PEPCK has a role during catalysis that consists of stabilization of the R-loop and lobe 
closure, correctly positioning substrates in the active site, and sequestering and protecting the 
reaction intermediate.  
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Figure 2-5. Active site and whole protein overlay of Ld_3g and Wt 
Overlay of Ld_3g and WT PEPCK in complex with oxalate and GTP. Removal of the lid region 
alters the ability of the enzyme to stabilize the structural changes necessary for PEPCK catalysis 
to occur. Above the WT whole protein is blue, with the loops and substrates in red. Ld_3g whole 
protein is grey, the loops and substrates in yellow (note the R-loop is observed in two 
conformations). A) zoomed in look at the mobile regions, B) whole protein view.    
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Chapter 3 Disruption of the free energy profile by mutagenesis 
Introduction 
Phosphoenolpyruvate carboxykinase (PEPCK) catalyzes the reversible decarboxylation of 
oxaloacetate (OAA) with subsequent phosphorylation to form PEP, utilizing GTP as the 
phosphate donor as shown in Figure 1-2. Bacteria, yeast, and certain plants use ATP. While in 
vitro the reaction is freely reversible, the consensus is that in most organisms PEPCK operates 
primarily in the direction of PEP synthesis. One of the exceptions is Ascari Suum, which fixes 
CO2 and synthesizes OAA to replenish the TCA cycle (22). PEPCK is a metal-requiring enzyme 
demonstrating an absolute requirement on divalent cations for activity. Mn
2+
 is the most 
activating cation in the GTP dependent isoforms (18-20). In addition a second divalent metal ion 
is required for the reaction, as the metal-nucleotide complex is the true substrate; Mg
2+
 and/or 
Mn
2+
 is able to fulfill this role. In higher eukaryotes PEPCK is present as both a cytosolic and 
mitochondrial isoform, with the relative distribution in the liver of the two isoforms being 
species dependent (Table 1-1) (2, 3, 6).  Biologically cPEPCK functions as a key cataplerotic 
enzyme, removing TCA cycle anions for usage in downstream metabolic pathways. In addition 
to PEPCKs well-characterized role in gluconeogenesis, it also participates in the lesser known 
pathways of glyceroneogenesis and triglyceride biosynthesis, as well as the synthesis of serine 
(reviewed in (9)) (Figure 1-1).  In contrast, the role of mPEPCK in metabolism is relatively 
unknown.  
The recent structural studies on PEPCK have revealed many details about the enzyme during 
the catalytic cycle. First and foremost, the structures illustrated the cationic active site, composed 
of the two divalent metal ions, and specific lysine and arginine residues that are positioned to 
readily carry out the reversible decarboxylation/carboxylation and phosphoryl transfer half-
reactions (Figure 1-9) (5). Based on the stepwise reaction pathway (Figure 1-2), it was postulated 
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that the enzyme forms a highly reactive enolate intermediate that must be stabilized and 
protected for catalysis to proceed. It has been suggested that this protection/stabilization is what 
allows for the reversible nature of the PEPCK catalyzed reaction (5). Another informative aspect 
of the structural studies was the revelation that conformational changes are occurring at the 
active site during the catalytic cycle (5, 24-27). These previously unappreciated movements 
included an eleven-residue Ω-loop lid domain, reminiscent of a similar domain found in TIM 
(53-56). The data suggest that only upon lid closure are the substrates correctly positioned for 
phosphoryl transfer. Furthermore, closure of the lid may result in the sequestering/protection of 
the reactive enolate, allowing PEPCK catalysis to proceed via the stepwise mechanism illustrated 
in Figure 1-2. 
The dynamic nature of lid opening and closing raises the questions of what is the energetic 
driving force for lid closure and what specific role lid closure plays in the catalytic cycle. The 
structural data on PEPCK demonstrated that no direct contacts are made between the lid when it 
closes and the substrates in the active site. This is in contrast to the Ω-loop on TIM which 
directly interacts with its substrate through the phosphate “gripper” (46). The single interaction 
the Ω-loop lid of PEPCK makes upon closing is between His-470 and Glu-89 (Figure 3-1). Glu-
89 makes a second interaction with Arg-87, which directly stabilizes the OAA substrate in the 
active site. Observing this indirect interaction pathway between the Ω-loop and the substrates led 
us to propose a model consistent with the notion put forth by Fersht and Jencks (36, 37). In this 
model, as the ligands add to the enzyme a portion of their Gibbs free energy of binding is 
partitioned to the protein, resulting in a shift in the thermodynamic favorability of the enzyme 
adapting an alternative conformation. In the case of PEPCK this alternative conformational state 
would be the energetically unfavorable closed lid conformation.  The remodeling of the free 
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energy profile via the energy partitioning can offset the entropic penalty the lid pays when 
assuming an ordered closed conformation rather than a mobile open (inactive) state (27). Recent 
NMR studies on TIM suggest that it operates under a similar mechanism in which the open-close 
equilibrium is ligand dependent (46). These results are consistent with the proposed model for 
PEPCK lid motion.  
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Figure 3-1. Ω-loop interactions in closed conformation. 
A potential energetic pathway between the Ω-loop and the active site ligand with the residues 
involved, shown as ball-and-stick (carbon-gray, nitrogen-blue, and oxygen-red), and the 
interactions, between OAA (burgundy) and the Ω-loop (yellow), shown as dashed lines. The 
other structural features and cofactors are shaded as follows: P-loop is red, R-loop is black, GTP 
is magenta, and the M1 and M2 Mn
2+
 ions are coral.  
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In order to test our model, that a portion of the Gibbs free energy of binding is partitioned to the 
enzyme to offset the reduction in conformational entropy upon lid ordering, and to further probe 
the role of lid closure, I have generated two sets of mutants. The first mutant is a lid mutation 
(A467G - Figures 3-1 & 3-2) designed to increase the entropic penalty for ordering the lid in the 
closed conformation. The second set is three R-loop mutations (E89A, D, Q - Figure 3-1 & 3-3) 
designed to disrupt the free energy pathway between ligands binding at the OAA/PEP site and 
the lid domain. Structural, kinetic, and thermodynamic characterization was performed on each 
of the four mutants.   
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Figure 3-2. A467G mutation 
Amino acid sequence of WT and A467G PEPCK with the site of the mutation in bold and 
underlined. The Ω-loop amino acid sequence is italicized. 
 
 
 
 
Figure 3-3. E89 mutants 
Amino acid sequence of WT and E89A, D, & Q PEPCK with the site of the mutation in bold and 
underlined. The R-loop amino acid sequence is italicized. 
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Results 
Kinetic experiments were performed to determine the effect of mutation upon the kinetic 
constants for the reaction in both the direction of PEP formation and OAA formation, as well as 
the OAA decarboxylase activity (Table 3-1 and 3-2). Further kinetic experiments were carried 
out to determine inhibition constants for the substrate analogues in lieu of a true thermodynamic 
measurement (Table 3-2C). However, thermodynamic experiments were utilized to determine 
binding constants for the GTP and GDP nucleotides via intrinsic protein fluorescence quenching 
(Table 3-2C). The data presented in the tables show two different WT values for each 
measurement, due to a change in the expression/purification of PEPCK between the A467 
(pGEX vector) and the E89 (pSUMO vector) mutants and also a change in conditions for certain 
assays. The change in expression system changed the full length enzyme; pGEX has additional 
glycine and serine residues on its N-terminus due to how the GST tag is cleaved from PEPCK by 
thrombin. Fits for all of the primary kinetic and thermodynamic data can be found in Appendix 
three. The structural data and refinement statistics can be found in Appendix four. 
Kinetic Characterization of recombinant WT and mutant PEPCK enzymes. 
 OAA  PEP. In the physiological direction, where OAA is converted to PEP, a mixed metal 
assay (assay A) was utilized, as the background rate of non-enzymatic OAA decarboxylation is 
lower in the presence of high concentrations of magnesium when compared to using manganese 
as the sole divalent cation. Utilizing this assay, A467G PEPCK has a 14-fold higher KM value for 
OAA than WT (Table 3-1A); E89A has a 23-fold higher KM; E89D has a 32-fold higher KM 
value; and E89Q has a 29-fold increase in the KM for OAA versus WT. This increase in KM is 
coupled with a reduction in kcat (26% 8%, 29%, and 19% of WT, respectively), resulting in a 
reduction in catalytic efficiency (kcat/KM,OAA) by two to three orders of magnitude (1.9%, 0.4%, 
0.9%, and 0.7% of WT). Conversely, there is little change in the KM for GTP resulting in the 
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kcat/KM,GTP decreasing by less than a factor of three for A467G, decreasing 8-fold for E89A, 3-
fold for E89D, and by less than one for E89Q. As described below, all of these mutants produce 
pyruvate during the turnover of OAA to PEP. The data for the formation of PEP that is coupled 
to pyruvate kinase and lactate dehydrogenase was corrected for this pyruvate formation activity.  
PEP  OAA. In the reverse direction PEPCK catalyzes the formation of OAA from PEP 
(assay B). The mutant A467G and the E89 mutants (A and Q) showed a decrease in the KM value 
for PEP (21%, 32%, and 32% of WT respectively), while the E89D mutant had no change in the 
KM for PEP compared to WT (Table 3-1B). In contrast, all of the mutants have drastically 
reduced kcat values (1-5% of WT). The combination of a decrease in KM and a decrease in kcat 
results in only a factor of four reduction in the kcat/KM for A467G, while the E89 mutants have a 
20-fold reduction relative to WT. On the other hand, the KM values for GDP were elevated 
slightly, which resulted in the kcat/ KM,GDP being decreased to less than 1% of WT for E89A and 
Q and less than 3% of WT for A467G and E89D.  
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Table 3-1. Kinetic characterization in the physiological direction and its reverse. 
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Pyruvate formation. It has been well documented that PEPCK catalyzes the production of 
pyruvate from OAA (57-60). With rat cPEPCK at 25C, this activity is dependent on the 
presence of GDP (assay D). When comparing the mutant and WT enzymes, A467G has a KM 
value seven-fold higher than WT with a modest reduction in kcat (57% of WT). The E89 mutants 
have KM values that are slightly elevated (all three are less than 2-fold) and a modest reduction in 
kcat (A-65%, D-59%, and Q-56% of WT). This results in the WT enzyme being 20-fold more 
efficient at catalyzing the decarboxylation of OAA than the A467G mutant but only 2-fold more 
efficient than the E89 mutants (Table 3-2B).  
All of the mutations were designed to reduce the favorability of the enzyme adapting the lid 
closed state and test our proposed role for the lid in protecting the enolate intermediate, once 
formed, from favorable protonation (vide infra). To this end, we investigated the ability of the 
enzyme to catalyze the formation of pyruvate during the catalyzed formation of PEP from OAA 
(assay C). In the WT enzyme there was no measurable formation of pyruvate at 25 C. However, 
each of the point mutations showed a measureable amount of pyruvate formation, albeit with a 
KM value similar to the elevated KM observed in both the decarboxylation reaction and the 
overall reaction in the direction of PEP formation, both described above (Table 3-2A). 
Inhibition of WT and A467G PEPCK by substrate analogs. The competitive inhibition of 
PEPCK by the substrate analogues SP and PGA and the enolate mimic oxalate have been 
illustrated previously on both mitochondrial and cytosolic isoforms of PEPCK (Figure 3-4) (26, 
61). The kinetic and structural data demonstrate that all three inhibitors are excellent mimics of 
the respective substrate/intermediate (Figure 3-4). We utilized the binding constants determined 
from the inhibition experiments to assess whether the mutations had any effect on substrate and 
enolate affinity. For the OAA analogue (SP) the affinity in A467G is roughly unchanged, 
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however, the affinity in all three E89 mutants is increased by ~6-fold (Table 3-2C). For the PEP 
analogue (PGA) only the A467G and WT were tested, with the resultant affinity values being 
unchanged. In contrast, the reduction in the affinity of oxalate is significant in all mutants, with 
A467G being increased by ~8-fold, while the E89 mutants are altered by at least 200 times, with 
the largest, E89Q, differing from the WT by a factor of 660.  
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Figure 3-4. Substrates and analogues 
The physiological substrates are shown on the left with the corresponding analog show in the 
right handle column.  
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Nucleotide binding by fluorescence quenching.  
The KM values for GDP and GTP suggest that the mutations have little effect on the relative 
affinity of PEPCK for the nucleotide substrates.  This conclusion was confirmed by the direct 
measurement of the KD values for IDP and ITP by intrinsic protein fluorescence quenching 
experiments. The inosine nucleotides were substituted in place of guanosine to reduce the inner 
filter effect observed when guanosine nucleotides are utilized. PEPCK utilizes inosine and 
guanosine nucleotides with similar catalytic efficiency, while ITC experiments on the human 
enzyme have demonstrated the exocyclic C-2 amino group of guanosine nucleotides increases 
the affinity of the enzyme for guanosine nucleotides by approximately an order of magnitude 
over that of the inosine analogue. As shown in Table 3-2C, WT PEPCK and all of the mutants 
have similar KD values for ITP and IDP.  
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Table 3-2. Pyruvate production and substrate affinities. 
  
 59 
Structural characterization of A467G, E89A, E89D, and E89Q.  
In order to demonstrate that the mutations created decrease the thermodynamic favorability of 
the enzyme adapting the closed lid conformation, the structures of each mutant PEPCK were 
solved in complex with SP, PGA, and oxalate and either GTP or GDP. Final data statistics for 
A467G can be found in Appendix 4. The statistics for the E89 mutants are not as complete as the 
A467G mutant due to an inherent property of the protein within the crystal lattice in which the 
N- and C-terminal domains are not in a single conformation, resulting in C-terminal lobe 
disorder and that makes refinement difficult. However, the electron density at the active site of 
each structure is well defined allowing for observations to be drawn from the data (Figure 3-5).  
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Figure 3-5. Active site region of E89A, D, and Q with electron density. 
The unique nature of the E89 mutants has resulted in the enzyme sampling the closed 
conformation. This has made refinement of the data more difficult, however, the active site is 
well ordered in each of the three mutants. Structures of PEPCK-βSP–Mn
2+
–Mn
2+
GTP A) E89A, 
B) E89D, C) E89Q. βSP, GTP and the active site residues involved in binding are modeled with 
electron density (rendered at 1.3σ).  
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As mentioned above, the structures of each mutant in the Michaelis-like and the enolate-
intermediate-like complexes were solved. Identical structural studies on the WT enzyme 
demonstrated that as the enzyme commits to catalysis the thermodynamic favorability of the 
enzyme adapting the closed lid conformation increases (see lid changes in Figure 1-9) (27). In 
the forward and reverse Michaelis complexes, SP-GTP and PGA-GDP, respectively, the WT 
enzyme contains two molecules in the ASU, with one adapting a closed lid conformation and the 
other one remaining open. In the oxalate-GTP complex with WT enzyme, the lid was always 
found to be in a closed conformation. In contrast to those results, and consistent with the design 
of the mutations, the structures of A467G, E89A, E89D, and E89Q with SP-GTP and PGA-
GDP were found to only adapt the open lid conformation, consistent with a destabilization of the 
closed lid state. In a similar fashion to the WT, the A467G–oxalate–Mn
2+
–Mn
2+
GTP structure 
contains two molecules in the ASU in which molecule B possess an open lid conformation. 
Molecule A was found to partially adapt a closed lid conformation that was manually adjusted to 
an occupancy of 70% (Figure 3-6). This results in an overall occupancy of the closed lid 
conformation for the crystal of 35%, compared to 100% in the WT enzyme. Upon comparison of 
the closed lid conformation observed in molecule A with the conformation of the closed lid in 
the WT PEPCK-oxalate-GTP structure (PDB ID: 3DT4), it is observed that the substitution of 
glycine for alanine does not change the low energy conformation of the closed lid (Figure 3-6).  
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Figure 3-6. A467G lid closed complex 
The substitution of a glycine for alanine 467 has not altered the low energy conformation of the 
Ω-loop lid. The left panel has the amino acid residues displayed with the electron density 
rendered at 1.5σ. Right-hand panel is the ribbon diagram of the active site mobile elements.  
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On the other hand, not a single E89 mutant adapts a closed lid conformation (even partially) in 
the structure with oxalate and GTP. In fact the structural data for two of these mutants (E89A 
and E89Q) illustrated the motional properties of the R-loop (discussed in Chapter 2), it flips out 
by 6 Å (Cα to Cα distance of R87) (Figure 3-7). This movement results in arginine 87 occupying 
space where the Ω-loop lid would normally reside when in the closed conformation. The R-loop 
in the E89D structure with oxalate-GTP is not observed to be flipped out; but the B-factors are 
extremely high compared to other regions of the structure, and the electron density in the R-loop 
region is not as complete as other less mobile areas of the structure. While the closed lid state is 
not observed in the E89 mutants, the kinetic results presented in Table 3-1 can only result if the 
lid is stabilized in the closed conformation to correctly position the substrates and amino acid 
side chains within the active site. Combining all of the structural data, and keeping in mind the 
kinetic results, confirms that the introduction of the individual point mutations allows the 
perturbation of the thermodynamic favorability of the enzyme adapting the closed lid 
conformation, necessary for catalysis, without altering the low energy conformation of the closed 
lid. 
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Figure 3-7. E89A and WT PEPCK active site overlay 
Overlay of WT (blue) and E89A (red) PEPCK–oxalate–Mn
2+
–Mn
2+
GTP complexes. The 
changes in the position of the mobile elements due to the introduction of the mutation at Glu-89 
is illustrated. 
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Discussion 
Mobile loop regions have been observed in multiple enzymes (PEPCK, TIM, and S-
adenosylmethionie synthetase) and shown to be essential for enzymatic activity (45-50). One 
enzyme in particular, TIM has a mobile -loop lid domain that has been extensively 
characterized. In one study a portion of the lid was removed, which led to an increase in 
production of the reaction side product methylglyoxal and negatively affected catalytic function, 
by no longer stabilizing the reaction intermediate (43). In another study, mutations designed to 
increase the motional freedom of the lid were introduced in the hinge region of the -loop of 
TIM. This set of mutations significantly impaired catalytic activity, but did not result in an 
increase in the production of methylglyoxal (46, 47). In general, these studies on TIM may 
demonstrate a common feature of mobile loop domains, in which a balance between rigidity and 
flexibility is necessary for catalytic function (46, 47, 62).  
PEPCK and TIM catalyze two different chemical reactions. However, both PEPCK and TIM 
catalyze their respective reactions via a mechanism in which the chemistry proceeds through an 
unstable enolate intermediate. The intermediate from either reaction is highly reactive and will 
rapidly decompose in solution. Based upon the common structural feature of a mobile Ω-loop 
that is coupled to ligand binding, two hypotheses can be made for the role of the Ω-loop lid in 
PEPCK. First, the mobility of the lid is necessary for ligand association/disassociation; and 
second, during catalysis the lid closes over the active site to sequester and/or stabilize the 
reactive intermediate and prevent its favorable protonation.  
While the two enzymes have the common structural feature, the mechanism of lid-closure 
stabilization is different. In TIM the lid domain forms a hydrogen bond with the phosphate of 
dihydroxyacetone phosphate (54, 55). In contrast, when the lid of PEPCK closes it makes no 
direct contacts with the bound substrates or the enolate intermediate. Therefore, in PEPCK, lid-
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closure cannot be stabilized by new interactions between the lid and the substrates. In light of 
this difference, an alternative mechanism is needed to explain how the transition between open 
and closed lid states is driven, energetically.  
The current model for the dynamic motions of PEPCK, in particular the Ω-loop, proposes that 
the free energy of substrate association is split between forming a tight binding E-S complex and 
being partitioned to the protein to offset any unfavorable entropic penalties for ordering of 
mobile elements. The energy that is partitioned to the protein, upon substrate binding, alters the 
free energy landscape. The free energy change allows the closed lid state to become 
thermodynamically favorable (27). This general idea has been presented previously (36, 37).  In 
order to understand the role of the lid domain in the reaction mediated by PEPCK, I have 
undertaken structural and kinetic studies of four mutant isoforms of the enzyme. The mutations 
were designed to alter the equilibrium of the open/closed transition while probing the pathway by 
which the free energy is partitioned.  
The rationale behind the A467 and E89 mutations 
To test the free energy model of lid dynamics in PEPCK catalysis described above, two 
approaches were devised. The first was to increase the entropic penalty for lid closure, and the 
second to disrupt the free energy pathway between the active site and the Ω-loop. To test the 
model by these methods, the available interaction energy was kept constant by utilizing the same 
substrates and analogues previously used to characterize the WT enzyme.  To achieve the first 
goal, a modified lid domain was engineered by the replacement of Ala-467 with the more 
conformationally flexible glycine to increase the entropic penalty for lid closure while 
maintaining the ability of the -loop to function as a singular rigid domain. To disrupt the free 
energy pathway, three separate mutations at Glu-89 were introduced: an alanine (to completely 
remove the side chain beyond Cβ), aspartate (to maintain the polar charged head group but 
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shorten the length by one carbon), and glutamine (to maintain the size of the side chain but 
eliminate electrostatic interactions). Glu-89 was chosen as the site to mutate because it interacts 
with both His-470 on the Ω-loop, and Arg-87 on the R-loop (R87 directly interacts with 
OAA/PEP). A mutation at this location will disrupt the only interaction the Ω-loop makes when 
it closes, therefore, the transfer of free energy will be disrupted. Upon expression and 
purification of each mutant (A467G, E89A, E89D, E89Q), structural and functional studies were 
performed to determine if the mutation provided data are consistent with our model of loop 
function. 
Structures of the Michaelis and enolate intermediate-like complexes 
The structures of A467G, E89A, E89D, and E89Q-PEPCK mimicking the forward (βSP-GTP) 
and reverse (PGA-GDP) Michaelis complexes and the enolate intermediate complex were 
determined under identical conditions as the previously determined WT structures (PDB ID: 
3DTB, 3DT2, 3DT7) (27). All twelve structures illustrate that no gross structural changes have 
been induced by the introduction of the mutations (Figure 3-8). However, consistent with the 
design of these mutations, the lid-closed state has become less thermodynamically favorable. 
This results in the closed lid state only being observed at a low population (35% of total 
molecules) in the A467G–oxalate–Mn
2+
–Mn
2+
GTP complex (Figure 3-6), and not at all in the 
E89A, D, & Q oxalate-GTP complexes. Similarly, the Ω-loop in the two Michaelis-like 
complexes is observed to be open 100% of the time in all of the mutant enzymes. These results 
contrast identical experiments on the WT enzyme in which the forward and reverse Michaelis-
like complexes have a 50-50 distribution of lid open/closed states, and the intermediate complex 
only possess a closed lid conformation. There are two important structural features that warrant 
addressing. First, the population of molecules in the A467G–oxalate–Mn
2+
–Mn
2+
GTP structure 
that do adapt the closed lid conformation demonstrate that the substitution of glycine for alanine 
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has not altered the structure of the Ω-loop (Figure 3-6). This allows the kinetic data to be 
interpreted in the context of the mutation disrupting the favorability of the closed lid state 
without other structural effects. The second observation from the structural work involves two of 
the E89 mutants (E89A and E89Q). In the structures with oxalate and GTP, the Ω-loop is open 
as mentioned above, but the R-loop adapts a new conformation. The move involves residues 86-
89 being displaced or flipped out (Figure 3-7). At the furthest point the Cα of R87 is 6 Å from its 
normal orientation. This flipping out, combined with the removal of the interaction between E89 
and H470, disrupts the ability of the Ω-loop to form a stable closed-lid complex and allows water 
molecules to fill the void left by R87. This rearrangement is only observed in the oxalate-GTP 
structures of the E89A and E89Q mutants, which suggests that the polar charged head group of 
glutamate and the interactions it makes with R87 and the Ω-loop play a role in 
stabilizing/orienting the R-loop. The flipped out R-loop is not observed in the E89D mutation 
because the polar charged head group is available to interact with R87, but the crystallographic 
B-factors for this region are high compared to the rest of the structure. The combination of the B-
factors being high and the electron density not being complete suggests that the R-loop has a 
certain amount of disorder in this structure. This is due to the shortening of the amino acid by 
one carbon, presumably creating a gap that is too large for the stabilizing interaction with H470 
to be made. The stabilization of the R-loop consequently aids in the stabilization of the enolate 
intermediate so that phosphoryl transfer can occur. Unfortunately, the crystallographic data are 
limited to observing the low energy conformation due to packing in the crystal lattice. This 
limitation prevents the determination of whether the shift in equilibrium towards the lid open 
conformation is due to a decrease in the closing rate or an increase in the opening rate. A 
previous study on TIM increased the entropic freedom of the Ω-loop, with the results showing 
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that the increased freedom did not lead to an increased rate of lid opening, but did lead to a 
decreased frequency of lid closure (47). Therefore, further studies on PEPCK will be necessary 
to see what effect increasing the entropy of the lid domain and decreasing the free energy 
transfer has on lid domain opening and closing rates.  
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Figure 3-8. Whole protein overlay between WT and A467G or E89A 
Structures of E89A (A-grey, mobile elements are red) and A467G (B-grey, mobile elements are 
red) solved in complex with oxalate and GTP superposed on the identical structure of WT 
PEPCK (Blue, mobile elements in cyan). 
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Lid closure stabilizes the enolate intermediate 
The enolate of pyruvate is a highly reactive intermediate formed during the conversion of OAA 
to PEP. As such, its stabilization and protection from protonation is a requirement for this 
conversion to occur. In the WT PEPCK–oxalate–Mn
2+
–Mn
2+
GTP structure, it was observed that 
stabilization of oxalate arises from the rotation forward of Y235, and its interactions with R87, 
and coordination to the M1 manganese ion. When the lid is closed, Y235 is observed to occupy a 
rotameric position in which the phenolic side chain is oriented towards the oxalate and the M1 
manganese (Figure 1-9C & D) (27). In a study of Y235 mutants it was proposed that an anion 
quadrapole interaction is formed between the tyrosine in the forward orientation and the enolate, 
aiding in stabilization (59). In molecule B of the A467G PEPCK–oxalate–Mn
2+
–Mn
2+
GTP, 
structure oxalate is bound at the active site, yet Y235 occupies a rearward orientation, too far 
away to form a stable interaction. This orientation of Y235 is also observed in all of the E89 
mutants when oxalate is bound. The coincident nature of lid closure and the stabilization of the 
forward rotamers of Y235 in the presence of oxalate are illustrated by molecule A of the A467G 
PEPCK–oxalate–Mn
2+
–Mn
2+
GTP structure. Molecule A possesses a mixture of open and closed-
lid states and a mixture of forward and rearward Y235 rotameric states. This shift in the low 
energy conformation of Y235 would appear to play a role in the observed increase in Ki for all 
four mutant PEPCK’s (Table 3-2). The structural studies on the E89 mutations gave further 
insight into the mechanism of stabilization for the enolate intermediate. As detailed in Figure 1-
9, the interactions between R87 and the OAA/enolate/PEP ligand are required for enzymatic 
activity (R87 mutations resulted in an enzymatically inactive isoform of PEPCK, data not 
shown). It was observed from the E89 mutant structures with oxalate-GTP that the R-loop has a 
higher level of disorder than the WT or has completely flipped, out occupying space where the 
Ω-loop lid would reside in the closed conformation. This results in the loss of R87 interaction 
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with oxalate, and by extrapolation, with the enolate intermediate. The loss of interaction with 
R87 coupled with the rearward rotameric state of Y235 results in an increased Ki (8-600 times 
that of WT) being observed for all mutants (Table 3-2). Furthermore, the decrease in affinity for 
oxalate, by the E89 mutants, could be due to the enzyme requiring more binding energy to 
stabilize the R-loop, as it is no longer stabilized through its interactions with H470. A related 
observation is that the hydration state of the active site has been altered when Y235 is in the 
rearward orientation and the R-loop flips out. This alteration may not contribute to the weakened 
affinity of the enzyme for the enolate/oxalate, but the change in water structure could account for 
the pyruvate formation observed in each of the mutants. The repositioned water molecules could 
potentially create an environment in which they are able to protonate the enolate intermediate. 
The protonation event is not observed in the WT enzyme at 25 °C. Currently it is not known 
whether the enolate is protonated on the enzyme or in solution upon release, but considering the 
KD for pyruvate is nine mM (61) a protonation event on the enzyme would provide a mechanism 
by which the tightly bound enolate intermediate could be released.  
Kinetic consequences of the disruption of lid dynamics 
Previous structural data on PEPCK demonstrate that the enzyme follows an induced fit 
mechanism of substrate binding. This results in the true enzyme-substrate not being formed until 
the Ω-loop lid closes over the active site. Based upon this observation, the kinetic schemes in 
Figures 3-10, 11, 12 are proposed to interpret the kinetic data for the WT and mutant (A467G, 
E89A, E89D, and E89Q) enzymes. These schemes may be an oversimplification but a two-state 
model would incorrectly define the open/closed conformations and a more in depth look at the 
different ensemble of protein states is excessive. The low energy trajectory illustrated by Figures 
3-10, 11, 12 is reasonable for the interpretation of the kinetic data in Tables 3-1 and 3-2.  
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The decarboxylation of OAA 
The reaction catalyzed by PEPCK can be split into two half-reactions, the decarboxylation of 
OAA and the phosphoryl transfer from GTP to the enolate intermediate. It was observed from 
measurements of the decarboxylation half-reaction that the mutations at A467 and E89 only 
modestly affect (A467G ~8-fold, E89 less than 2-fold) the KM for OAA (Table 3-2B) and 
slightly decrease the rate of decarboxylation. As illustrated in the kinetic scheme (Figure 3-9), 
this KM value represents the binding of OAA to the PEPCK-GDP complex and the 
opening/closing of the Ω-loop. This conclusion is reached based upon two pieces of data: 1) the 
decarboxylation activity is only observed in the presence of GDP and 2) structural data on the 
WT–OAA–Mn
2+
–Mn
2+
GDP complex demonstrates it has an increased propensity for lid-closure 
(PDB ID: 2QF2), similar to the WT Michaelis-like complexes (PDB ID: 3DTB and 3DT7) (27). 
This shift in equilibrium to the closed conformation stimulates the decarboxylation of OAA 
generating the enolate and CO2. Both of these pieces of data are consistent with the idea that 
decarboxylation is only initiated after lid-closure. However, since GDP is utilized in this assay 
there is no transferable phosphoryl group available to phosphorylate the enolate. This results in 
pyruvate being formed and released the next time the lid samples the open conformation. Based 
upon the proposed kinetic scheme (Figure 3-9), the observed increase in the KM for OAA in all 
of the mutants could result from either an increase in k2, kopen, or koff, or a decrease in kon or kclose. 
All of the values obtained for k2 in the mutant enzymes were slightly decreased compared to 
WT, therefore in the wrong direction to cause an increase in KM. To try to better understand if 
the kon/koff or kclose/kopen step is the reason for the modest increase in the KM, inhibition studies of 
PEPCK by βSP (OAA analog) were undertaken. The inhibition data for A467G suggest that kon 
and koff are only modestly affected, since the binding of βSP only differs by a factor of 2 between 
the WT and A467G.  This minimal effect on binding could be a bi-product of altered lid 
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dynamics, kopen/kclose rates, in the PEPCK-GTP state. The altered rates of opening and/or closing 
can affect kon/koff, as the structural studies illustrated that binding of substrates cannot occur after 
lid closure (27). Inhibition of the E89 mutants resulted in a decrease in affinity for βSP (~6 times 
WT), suggesting that kon and koff are slightly more affected by a mutation at glutamate 89. The 
change in affinity is not totally unexpected due to the proximity of the mutation to R87 on the R-
loop. However, this slight change in kon and koff does not result in a significant increase in the KM 
for OAA. On the contrary, the KM’s for OAA measured for the E89 mutants were not even 
elevated 2-fold, which suggests that the mutation alters the kopen and kclose step leaving the KM 
relatively unchanged. This explanation for the disrupted lid behavior has been used before on 
kinetic data of hinge mutations in TIM(47). Therefore, the structural and kinetic data are 
consistent with the modest increase in KM resulting from a shift in the open-closed lid 
equilibrium favoring the open lid conformation. 
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Figure 3-9.Decarboxylation kinetic scheme. 
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The OAA  PEP reaction 
In the physiological reaction catalyzed by PEPCK, the mutations introduced result in a 14-32 
fold increase in the KM for OAA, coupled with a decrease in kcat (8-29% of WT) (Table 3-1). 
Similar to what was discussed above for the decarboxylation half-reaction, the change in the KM 
value is due to either a decrease in the rate of lid-closure or an increase in the rate of lid-opening 
(Figure 3-10), effectively shifting the equilibrium of lid states to the open conformation, which is 
consistent with the design of the mutations and the structural data. All four of the mutant 
enzymes will form a stable lid-closed conformation in order to initiate catalysis. Assuming 
kcat~k3, the phosphorylation of the enolate intermediate is the potential rate limiting step of the 
reaction, since, it is envisioned that this step is the most energetically costly (Figure 3-12). 
Therefore, the observation of pyruvate formation by each of the mutant enzymes suggests that 
the rate of k3 has been altered (Figure 3-10). In WT k3 is fast compared to kreopen, as no pyruvate 
formation is observed, but in the mutants the equilibrium between the rates has shifted. The shift 
is caused by either a reduction in the phosphoryl transfer rate or an increase in the kreopen rate. 
This change results in pyruvate being produced at a rate of one molecule per five turnover events 
in A467G, 1:1 in E89A, 1:15 in E89D, and 1:3 in E89Q. To address whether pyruvate formation 
is caused by a slowing of the phosphoryl transfer step, kinetic studies on were carried out on WT 
PEPCK using the slowly hyrdrolyzable substrate 5’-O-(γ-thio)triphosphate (GTPγS). Usage of 
GTPγS reduces kcat (13s
-1
) and the KM is 39 µM. However, no pyruvate formation was observed 
using GTPγS. Therefore, the data suggest that the phosphoryl transfer step is not responsible for 
the decoupling of the reaction in the absence of a destabilization of the lid-closed conformation. 
 
 
  
 77 
 
Figure 3-10.Physiological direction kinetic scheme 
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The PEP  OAA reaction 
In contrast to the decarboxylation and physiological assays, the results from the reaction in the 
direction of OAA synthesis results in a decrease in KM, in three of four mutants, and a significant 
decrease in kcat for all four mutants. The data can be interpreted by the model presented in Figure 
3-11. Based upon the proposed kinetic scheme, the observed decrease in the KM for OAA 
(A467G, E89A, and E89Q) could result from either a decrease in k2, kopen, or koff, or an increase 
in kon or kclose. All of the values obtained for k2 with the mutant enzymes were significantly 
decreased compared to WT (A467G-5%, E89A-1%, E89D-3%, E89Q-1% of WT). Inhibition 
data were collected for WT and A467G using the substrate analog PGA. The results of that assay 
indicate that the affinity for PEP is slightly increased in the mutant enzyme, but increases by less 
than a factor of two (Table 3-2). The E89 mutants were not tested with PGA, as the substrate is 
no longer commercially available; however, the assumption is made that these mutants will act 
similarly to the A467G mutant (affinity for PGA slightly increased), as the other kinetic results 
have been similar. The minimal change in PGA affinity observed in the A467G mutant is not 
believed to cause the decrease in KM. In the kinetic scheme for PEPCK in the direction of OAA 
synthesis, lid closure does not stimulate decarboxylation and formation of the enolate, rather lid 
closure stimulates phosphoryl transfer from PEP to GDP. Based on the standard free energies for 
the reversible OAA to PEP reaction, it is envisioned that the phosphoryl transfer step is the most 
energetically costly (Figure 3-12). As a result the destabilization of the enolate intermediate by 
all of the mutant isoforms has a more drastic effect on the activation energy barrier for the 
reaction in the PEP to OAA direction. As a consequence, the reduction in k2 observed in A467G, 
E89A, and E89Q leads to the reduction in KM. However, the E89D mutant PEPCK had a KM 
value that is roughly equal to the WT, but yet still has a drastic reduction in k2. The explanation 
for this difference is that the rate of kclose/kopen or kon/koff has been altered to a different degree 
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than the A467G, E89A, and E89Q mutants. Further studies are needed to determine which step is 
affected. This interpretation of the data is also consistent with the lack of observed pyruvate 
formation during turnover by these mutant isoforms in the PEPOAA direction. On the basis of 
the free energy diagram the slow step, phosphoryl transfer, precedes enolate formation. The 
carboxylation step (k3) is expected to be significantly faster than the lid reopening rate (kreopen), 
resulting in a lack of pyruvate formation in this direction.  
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Figure 3-11. Reverse Physiological reaction kinetic scheme. 
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Figure 3-12. Cartoon  free energy diagram of PEPCK catalysis. 
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Chapter 4 Conclusion and Future directions 
Phosphoenolpyruvate carboxykinase is an important metabolic enzyme discovered in the 1950’s. 
Since that time it has been extensively characterized both metabolically and biochemically. In 
the mid 1990’s the first structure of PEPCK was solved by X-ray crystallography. Within the 
next decade over 40 structures had been solved of PEPCK in complex with multiple different 
small molecules. This led to PEPCK being mapped structurally along the reaction coordinate, 
with the intention of revealing any mobile regions that may be important for function. From 
these studies it was discovered that PEPCK has a number of structural features that have 
conformational flexibility. The structures revealed that as the enzyme progresses from the holo 
(metals bound) state, to the Michaelis complex, to the intermediate state certain structural 
features undergo a disordered/ordered (open/closed) transition. One of these mobile elements is 
an 11 amino acid Ω-loop, reminiscent of a similar structure in TIM, which acts like an active site 
lid. From the structural work a role in catalysis for the Ω-loop was proposed: the open/closing 
motion acts to correctly position substrates in the active site, sequester and protect the reaction 
intermediate, and aid in the transition between ground states. Furthermore, the transition is ligand 
gated, meaning the loop closure only occurs as substrates associate with the enzyme. This 
observation led to the question what is the energetic driving force behind lid closure. Unlike the 
loop in TIM, when the PEPCK Ω-loop closes it does not make any interaction with the substrates 
in the active site. However, the Ω-loop has a histidine residue (470) that forms a stable salt 
bridge with a glutamate (89) in the R-loop. The glutamate further interacts with arginine 87, 
which is directly involved in ligand binding. Upon seeing this interaction pathway, it was 
proposed that the energetic driving force for Ω-loop lid closure was the partitioning of enthalpic 
energy from ligand binding to offset any entropic penalty the lid must pay to close. To test this 
model I came up with a multi-faceted approach: first to investigate additional roles for the lid in 
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catalysis, I removed the lid; and second, to test the free energy partitioning, I created a lid mutant 
to increase the entropic penalty for lid closure and a mutation at Glu-89 to disrupt the proposed 
enthalpic energetic pathway.  
The results of my studies shed light on how the Ω-loop in PEPCK operates and allows a revised 
model to be proposed. From the lid removal mutants, it was observed that the Ω-loop is 
absolutely required for catalysis. More specifically, closure of the lid stabilizes the R-loop when 
the intermediate is bound and acts like a latch for N- and C-terminal lobe closure. The Glu-89 
and Ala-467 mutations illustrated that a very fine energetic balance exists and that at least a 
portion of the enthalpic energy partitioned to the lid from the OAA/PEP goes through the R87-
E89-H470 pathway. Taking into consideration all of the data from WT and each set of mutants, a 
revised model for PEPCK catalysis is proposed. The roles of the Ω-loop during the catalytic 
cycle are to aid in correctly positioning the substrates, stabilize the R-loop when the reaction 
intermediate is present, stabilize the N- and C-terminal lobe closure, and as a culmination of 
these other roles to sequester and protect the reactive enolate intermediate.  
The one piece of information really lacking from a complete understanding of the Ω-loop lid is 
the time-scale on which lid opening and closing occurs, and how the mutations affect these rates. 
At the present time multiple attempts have been made to obtain rate values with no success. As 
new techniques are devised and/or instrumentation becomes more sensitive, these measurements 
will be obtainable. The most recent attempt utilized NMR to measure a change in Met-476, 
which is in the hinge region of the Ω-loop lid. The preliminary results of this experiment suggest 
that this methodology may allow for the measurements of Ω-loop lid rates. The A467G mutation 
was designed to increase the entropy of the system; to further test the free energy balance, 
crystallographic and kinetic experiments utilizing a temperature change would lend support to 
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the enthalpy/entropy balance. The Glu-89 mutations disrupted the enthalpic free energy transfer,  
to build upon this and see if the pathway could be reestablished His-470 could be mutated to an 
arginine in the E89D mutant. This could allow the electrostatic interactions to reform, returning 
PEPCK to normal enzymatic function. Finally, the lid deletions created were extreme; if the lid 
was systematically shortened by removal of A466, A467, and A468, the role of the loop in 
positioning the substrates and protecting the reaction could be tested through structure function 
characterization.  
  
 85 
Chapter 5 Materials and Methods 
 
Creation of mutations  
Recombinant rat cPEPCK in pGEX-4T-2 (E. coli) was used as the starting vector to create the 
A467G mutation. Recombinant rat cPEPCK in pSUMO (E. coli) was used as the starting vector 
to create the Glu-89 mutants (E89A, D, Q), as well as the lid removal with subsequent 
replacement by one, two, or three glycine mutants (Ld_1,2,3g). The forward primer (Figure 5-1) 
and its reverse complement were utilized with the Stratagene Quik Change protocol. The 
resultant mutated DNA was isolated with a Hurricane cleanup kit from Gerard Biotech and 
subsequently sequenced to confirm the presence of the desired mutation and the absence of any 
additional mutations introduced via the PCR protocol. The plasmid DNA was transformed into 
E. Coli BL-21(DE3) electro-competent cells for expression.  
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Figure 5-1. Primers for mutagenesis.  
The 5’-3’ primers utilized to create the mutations discussed in chapters 2 and 3 are shown here. 
The 3’-5’ reverse complement was also synthesized.  
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Expression and Purification 
GSH tagged PEPCK  
Overnight cultures of BL-21(DE3) Escherichia coli cells containing the WT or A467G plasmid 
DNA in pGEX-4T-2 were grown at 37 °C at 225rpm in LB media supplemented with 200 μg/mL 
ampicillin. The cells were pelleted by centrifugation at 6000rpm for 15 min. The resultant cell 
pellet was resuspended and grown in 1.5L of LB-200 μg/mL ampicillin at 37 °C until the OD600 
reached 1.0-1.5. The cells were subsequently induced with 1mM IPTG and grown for an 
additional 4h. The cells were harvested by centrifugation at 6000rpm for 15 min and then stored 
at -80 °C. The frozen pellet was resuspended in buffer A [25mM HEPES, pH 7.5, 10mM DTT, 
10% glycerol 0.1% Synperonic NP30, 100mM NaCl, and 0.1mM EDTA] and lysed by two 
passages through a French pressure cell. The cell debris was pelleted by centrifugation at 
9000rpm for 15 min at 4 °C. Protamine sulfate at a final concentration of 0.1% was added to the 
supernatant and allowed to incubate for 20-30 min, after which the solution is centrifuged 3 
times at 14,000 rpm for 15min at 4 °C. After the final spin the supernatant was collected and 
incubated with glutathione-Uniflow resin for 1-2 h at 4 °C with stirring. The resin was poured 
into a column, allowed to settle, then washed with buffer A until the A280 was 0.1 or less. The 
resin was incubated overnight at 4 °C with 10 unit of thrombin (Bovine plasma). The resin was 
returned to the column and rinsed with Buffer 1 until the A280 was less than 0.1. The eluent was 
concentrated to ~15mL in an Amicon stirred cell, nitrogen concentrator using a 30 kDa filter and 
then loaded onto an anion exchange column (Hi-Q)  attached to a Biorad DuoFlow. PEPCK was 
eluted from this column using a gradient of buffers B [25mM HEPES, pH 7.5, 10mM DTT] and 
C [25mM HEPES, pH 7.5, 10mM DTT, 500mM NaCl]. The fractions containing the protein 
were pooled together and concentrated in the Amicon concentrator to a final volume of 3mL or 
less. The concentrated enzyme was subsequently loaded onto a P6DG column equilibrated in 
 88 
buffer B for desalting. The fractions with an A280 above 0.3 were pooled and concentrated with 
a 30 kDa centricon to a final concentration of 10mg/ml, determined by absorbance at A280 using 
a molar extinction coefficient of 1.65 mL mg
-1
. The protein was then flash frozen by pipetting 
30µL drops directly into liquid nitrogen. 
pSUMO tagged PEPCK 
Overnight cultures of BL-21(DE3) Escherichia coli cells containing WT, E89, or Ld mutant 
DNA in pSUMO were grown at 37 °C, 225rpm in LB media supplemented with 50 μg/mL 
kanamycin. The cells were pelleted by centrifugation at 6000rpm for 15 min. The resultant cell 
pellet was resuspended and grown in 1.5L of LB-50 μg/mL kanamycin at 37 °C until the OD600 
reached 1.0-1.5. The cells were subsequently induced with 1mM IPTG and grown for an 
additional 4h. The cells were harvested by centrifugation at 6000rpm for 15 min and then stored 
at -80 °C. The frozen pellet was resuspended in buffer A [25mM HEPES, pH 7.5, 2mM TCEP, 
10% glycerol, 10mM imidazole and 300mM NaCl] and lysed by two passages through a French 
pressure cell. The cell debris was pelleted by centrifugation at 9000rpm for 15 min at 4 °C. 
Protamine sulfate at a final concentration of 0.1% was added to the supernatant and allowed to 
incubate for 20-30 m, after which the solution is centrifuged 3 times at 14,000 rpm for 15min at 
4 °C. After the final spin, the supernatant was collected and incubated with Ni-NTA resin for 
0.1-1 h at 4 °C. After incubation, the resin was poured into a column, allowed to settle and 
washed with buffer A until the A280 was 0.1 or less. The protein was subsequently eluted from 
the Ni-NTA with buffer B [25mM HEPES, pH 7.5, 2mM TCEP, and 300mM imidazole]. The 
eluted protein was then incubated with 2.5mg of pSUMO protease for 1 h, concentrated to ~4mL 
in an Amicon concentrator with a 30kDa filter. The concentrated solution was applied to a P6DG 
desalting column equilibrated in buffer C [25mM HEPES, pH 7.5 and 2mM TCEP] to remove 
the imidazole. The fractions containing protein were pooled and reincubated with the Ni-NTA 
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resin (to remove the hydrolyzed pSUMO tag) for 30min and washed with buffer C till the A280 
was 0.1 or less as PEPCK was collected in the flow through. The sample was then concentrated 
to ~15mL and loaded onto an anion exchange column (Hi-Q) equilibrated in buffer D [25mM 
HEPES, pH 7.5, 10mM DTT] and eluted using a gradient of buffers D and E [25mM HEPES, pH 
7.5, 10mM DTT, 500mM NaCl]. The fractions containing the protein were pooled and 
concentrated in an Amicon concentrator to a final volume of 3mL or less. The concentrated 
enzyme is next loaded onto a P6DG desalting column equilibrated in buffer D to exchange the 
buffer. The fractions with an A280 above 0.3 were pooled and concentrated with a 30 kDa 
centricon till a final concentration of 10mg/ml, determined by absorbance at A280 using a molar 
extinction coefficient of 1.65 mL mg
-1
. The protein was then flash frozen by pipetting 30µL 
drops directly into liquid nitrogen. 
Kinetic assays 
All kinetic data were collected on a Cary 100 spectrophotometer equipped with a multi-cell 
changer and a temperature bath. PEPCK activity was assayed in both the physiological direction 
of PEP formation and the reverse direction of OAA formation using modifications of previously 
published assays (19, 57, 58, 61). All assays were performed at 25˚ C, in a final volume of 1 mL 
and monitored spectrophotometrically by following the decrease in absorbance at 340 nm due to 
the oxidation of NADH. The oxidation of NADH was recorded in real time so as to allow the 
calculation of a rate of enzyme activity from the extinction coefficient for NADH (?). In all 
kinetic assays the concentration of PEPCK utilized was as follows 14-36 nM for WT, 43-86 nM 
for A467G, 75-125nM for the E89, and 25-35nM for the lid deletion mutants. 
Assay A: OAA+GTPPEP+CO2+GDP.  
The decarboxylation and phosphorylation of OAA to form PEP was carried out utilizing two 
slightly different reaction mixtures. The WT and A467G mutant (from the pGEX construct) 
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reaction mixture contained 50mM HEPES pH 7.5, 10mM DTT, 4mM MgCl2, 500 µM GTP, 
1mM ADP, 200 µM MnCl2, 150 µM NADH, 30 units of LDH, 50 µg PK, and 350 µM (2mM for 
A467G) OAA. The WT and E89 mutant(s) (from the pSUMO construct reaction mixture 
contained 50mM HEPES pH 7.5, 10mM DTT, 5.8mM MgCl2, 450 µM GTP, 1mM ADP, 20 µM 
MnCl2, 150 µM NADH, 30 units of LDH, 50 µg PK, and 350 µM (2 mM for E89A,D,Q) OAA. 
All enzyme-catalyzed rates that use OAA as the substrate have been corrected for the non-
enzymatic decarboxylation of OAA forming pyruvate (Assays A, C, and D). This assay was 
started by the addition of OAA to each cuvette. OAA and GTP concentrations were varied from 
0.04-2mM and 6-450µM respectively to obtain the respective Michaelis constants. When OAA 
was varied, the reaction was performed as above. When GTP was the varied substrate, MgCl2 
was also varied to keep a constant 4:1 ratio of metal to nucleotide. The reaction mixture was 
preincubated at 25˚ C for 5 min prior to addition of OAA.  
Assay B: PEP+GDP+CO2OAA+GTP. 
The dephosphorylation and carboxylation of PEP to form OAA was measured using two 
different reaction mixtures, one for the WT and A467G from pGEX and the other for WT and 
E89A,D,Q from the pSUMO vector. For the WT and A467G the reaction mixture consisted of 
50mM HEPES pH 7.5, 10mM DTT, 4mM MnCl2, 500 µM GDP, 150 µM NADH, 2mM PEP, 10 
units of MDH, and 50mM KHCO3. For the pSUMO vector enzymes the assay mixture contained 
50mM HEPES pH 7.5, 10mM DTT, 17mM MgCl2, 20 µM MnCl2, 4 mM GDP, 150 µM NADH, 
5mM PEP, 10 units of MDH, and 50mM KHCO3. This assay was started by the addition of 
PEPCK to the reaction mix in the cuvette. PEP and GDP concentrations were varied in turn, 
0.04-5mM and 0.07-4mM respectively, to obtain the Michaelis constants. When GDP was the 
varied substrate MnCl2 (pGEX constructs) and MgCl2 (pSUMO construct) was also varied to 
keep a constant metal to nucleotide ratio of 4:1.  
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Assay C: OAA+GTP pyruvate+GTP+CO2.  
The decoupling of the PEPCK catalyzed reaction (Assay A) through the production of pyruvate 
was measured in the same reaction mix as assay A. The only exception was that the coupling 
enzyme pyruvate kinase (PK) and its required nucleotide (ADP) were omitted from the reaction 
mix so that the direct production of pyruvate by PEPCK could be monitored. For the A467G 
mutant each cuvette consisted of 50mM HEPES pH 7.5, 10mM DTT, 4mM MgCl2, 500 µM 
GTP, 200 µM MnCl2, 150 µM NADH, 30 units of LDH, and variable (0.04-2 mM) OAA. For 
the E89 mutants the reaction mixture contained 50mM HEPES pH 7.5, 10mM DTT, 1.8mM 
MgCl2, 450 µM GTP, 20 µM MnCl2, 150 µM NADH, 30 units of LDH, and variable (0.04-2 
mM) OAA. The reaction mixture was preincubated at 25˚ C for 5 min prior to addition of OAA 
to initiate the reaction.  
Assay D: OAA+GDPpyruvate+GDP+CO2.  
The PEPCK catalyzed decarboxylation of OAA without subsequent phosphoryl transfer was 
carried out under identical reaction conditions to assay C except that for A467G 500 µM GDP 
was substituted for GTP and for the E89 mutants 4.2mM GDP was substituted and the MgCl2 
concentration increased to 17 mM. A Michaelis constant for OAA was determined by varying 
OAA concentration. The reaction mixture was preincubated at 25˚ C for 5 min prior to the 
addition of OAA to initiate the reaction. 
Inhibition Assays.  
Inhibition experiments with oxalate and PGA were carried out using assay B for A467G and WT 
from pGEX. A Michaelis constant for PEP was determined at several fixed concentrations of 
each inhibitor. The inhibition by oxalate for the E89 mutants was carried out using assay A. 
Again, a Michaelis constant for OAA was determined at several fixed concentrations of oxalate. 
The inhibition by β-SP was carried out using assay A, for all of the mutants, as β-SP is a 
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substrate for the malate dehyrodgenase (MDH) coupling enzyme. Again, a Michaelis constant 
for OAA was determined at several concentration of β-SP. 
Data analysis for WT and A467G pGEX purified enzymes.  
All kinetic data was analyzed using SigmaPlot
® 
11. In assays A-D the slope of the line was used 
to calculate a rate of enzyme activity. Due to the production of pyruvate during the OAA  PEP 
reaction (Assay A) in the mutant enzyme, the data were corrected for this activity using the KM 
and Vmax values obtained for the enzyme from Assay C for the A467G enzyme. These two values 
were used in equation 1 to calculate the theoretical rate of catalyzed pyruvate formation at each 
substrate concentration used in Assay A for the A467G enzyme. This calculated rate was 
subtracted from the observed activity after correction for non-enzymatic, spontaneous OAA 
decarboxylation as described above.  All kinetic data were fit nonlinearly to the Henri-Michaelis-
Menten relationship (equation 1) to determine KM and Vmax values. A kcat value was calculated 
from the Vmax using a molecular weight of 69 415 Da. For the inhibition studies, all of the data 
were globally fit by the enzyme kinetics module in SigmaPlot
® 
11. For the inhibition of PEPCK 
by PGA and oxalate, the rate data was fit to equation 5-3 for competitive inhibition. For β-SP the 
data was fit to equation 5-4 for mixed inhibition. This is due to a contamination of the β-SP by 
sulfate. The value reported is the competitive inhibition portion of the data fit.  
Data analysis for pSUMO purified enzymes.  
All kinetic data was analyzed using SigmaPlot
® 
11. In assays A-D the slope of the line was used 
to calculate a rate of enzyme activity. Due to the production of pyruvate during the OAA  PEP 
reaction (Assay A) in the mutant enzymes, the data were corrected for this activity using the KM 
and Vmax values obtained for the enzyme from Assay C for the E89 mutants. These two values 
were used in equation 1 to calculate the theoretical rate of catalyzed pyruvate formation at each 
substrate concentration used in Assay A for the E89A,D,Q enzymes. This calculated rate was 
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subtracted from the observed activity after correction for non-enzymatic, spontaneous OAA 
decarboxylation as described above.  All kinetic data for the WT enzyme, except Assay D, were 
fit nonlinearly to the Henri-Michaelis-Menten relationship (equation 5-1) to determine KM and 
Vmax values. Data from Assay D were fit linearly to a Lineweaver-Burk relationship (equation 5-
2) to determine KM and Vmax values. Data from Assays A, C, and D were fit linearly to a 
Lineweaver-Burk relationship to obtain KM and Vmax values, with one exception Assay A for 
GTP. The data collected to obtain constants for GTP and Assay B were fit nonlinearly to the 
Henri-Michaelis-Menten relationship (equation 5-1) to determine KM and Vmax values. A kcat 
value was calculated from the Vmax using a molecular weight of 69 415 Da. For the inhibition 
studies on PEPCK by oxalate and β-SP, the rate data was plotted together and globally fit using 
equation 5-3 in the enzymes kinetic module for SigmaPlot
® 
11, resulting in a Ki value for the 
competitive inhibition of each substrate analog.  
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Equation 5-1. Henri-Michaelis-Menten relationship 
υ is the  initial velocity, Vmax is the maximal velocity achieved, [S] is the concentration of 
substrate at each velocity, and KM is the Michaelis constant for each respective substrate. 
 
Equation 5-2. Lineweaver-Burk relationship 
υ is the  initial velocity, Vmax is the maximal velocity achieved, [S] is the concentration of 
substrate at each velocity, and KM is the Michaelis constant for each respective substrate. 
 
 
Equation 5-3. Competitive inhibition  
υ is the  initial velocity, Vmax is the maximal velocity achieved, [S] is the concentration of 
substrate at each velocity, KM is the Michaelis constant for each respective substrate, [I] is the 
inhibitor concentration, and Ki is the inhibition constant. 
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Equation 5-4. Mixed inhibition 
υ is the  initial velocity, Vmax is the maximal velocity achieved, [S] is the concentration of 
substrate at each velocity, KM is the Michaelis constant for each respective substrate, [I] is the 
inhibitor concentration, and Ki is the inhibition constant. 
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Nucleotide Binding  
PEPCK’s affinity for nucleotide was determined using intrinsic fluorescence quenching 
experiments which were performed on a steady state PTI instrument with temperature control. 
Each assay was carried out in a triangular cuvette at 15˚ C with constant stirring. The reaction 
mixture for the pGEX enzymes contained 50mM HEPES, pH 7.5, 10mM DTT, 1mM MnCl2, 
200 µM KCl, and PEPCK (1-5 µM). The reaction mixture for the pSUMO enzymes contained 
50mM HEPES, pH 7.5, 10mM DTT, 1.4mM MgCl2, and PEPCK (1-5 µM). The emission was 
monitored at 330 nm after excitation at 295 nm. The sample was titrated with an identical 
solution, which also contained IDP or ITP. Inosine nucleotides were substituted for the 
guanosine nucleotides utilized in the kinetic studies to reduce inner filter effects. The binding 
constants and quenching maximums were determined by a nonlinear least squares fit of the 
titration data to equation 4 (IDP) or equation 5 (ITP). 
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Equation 5-5. Flourescence quenching 
QL is the quenching at each ligand concentration, QM is the maximal quenching observed, KD is 
the dissociation constant of the complex, LT is the ligand concentration titrated into the sample, 
and PT is the protein concentration.   
 
 
 
Equation 5-6. Fluorescence quenching 2. 
QL is the quenching at each ligand concentration, QM is the maximal quenching observed, KD is 
the dissociation constant of the complex, LT is the ligand concentration titrated into the sample. 
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Structural Studies 
 
Crystallization.  
Crystals of the complexes of A467G PEPCK were grown by vapor diffusion using the hanging 
drop method. The well solution consisted of 24-34% PEG 3350, 100mM HEPES pH 7.4, and 
water to obtain a final volume of 700μL. The crystals were grown on a siliconized cover slide in 
a liquid drop that contained 4μL of 10mg/mL protein, 2μL of the well solution, 0.5μL of 100mM 
GDP or GTP, and 0.5μL of 100mM MnCl2. The crystals were cryoprotected by soaking the 
crystal for 30min in a solution containing 25% PEG 3350, 10% PEG 400, 100mM HEPES pH 
7.4, 2mM MnCl2, 10mM GDP or GTP, and 10mM of the nucleotides corresponding ligand 
(PGA-GDP, βSP-GTP, or Ox-GTP). While cryoprotection occurs within seconds of immersing 
the crystal in the cryoprotectant the crystals were soaked for 30min to allow binding of the ligand 
in the active site. After the soaking period the crystals were cryo-cooled by immersion in liquid 
nitrogen.    
Crystals of the complexes of E89A,D,Q and Ld_1,2,3g PEPCK were grown by vapor diffusion 
using the hanging drop method. The well solution consisted of 22-26% PEG 3350, 100mM 
HEPES pH 7.4, and water to obtain a final volume of 700μL. The crystals were grown on a 
siliconized cover slide in a liquid drop that contained 4μL of 10mg/mL protein, 2μL of the well 
solution, 0.5μL of 30mM GDP or GTP, and 0.5μL of 75mM. The crystals were cryoprotected by 
soaking the crystal for 30-60 min in a solution containing 25% PEG 3350, 10% PEG 400, 
100mM HEPES pH 7.4, 2mM MnCl2, 5mM GDP or GTP, and 10mM of the nucleotides 
corresponding ligand (PGA-GDP, βSP-GTP, or Ox-GTP). The crystals were cryo-cooled by 
immersion in liquid nitrogen. 
Data Collection 
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Data on the cryo-cooled A467G PEPCK-Mn
2+
-βSP-Mn
2+
GTP, and A467G PEPCK-Mn
2+
-
oxalate-Mn
2+
GTP complexes maintained at 100K were collected at the Stanford Synchrotron 
Radiation Laboratory, Beamline 11-1, Menlo Park, CA. Data on the cryo-cooled E89A,D,Q 
PEPCK-Mn
2+
-βSP-Mn
2+
GTP, E89A,D,Q PEPCK-Mn
2+
-PGA-Mn
2+
GDP, and E89A,D,Q 
PEPCK-Mn
2+
-oxalate-Mn
2+
GTP complexes maintained at 100K were collected at the Stanford 
Synchrotron Radiation Laboratory, Beamlines 9-2 and 7-1, Menlo Park, CA. Data on the cryo-
cooled Ld_1,2,3g PEPCK-Mn
2+
-βSP-Mn
2+
GTP, Ld_1,2,3g PEPCK-Mn
2+
-PEP-Mn
2+
GDP and 
Ld_1,2,3g PEPCK-Mn
2+
-oxalate-Mn
2+
GTP complexes maintained at 100K were collected at the 
Stanford Synchrotron Radiation Laboratory, Beamlines 9-2 and 7-1, Menlo Park, CA. The Data 
on the A467G PEPCK-Mn
2+
-PGA-Mn
2+
GDP crystal maintained at 100K were collected using a 
RU-H3R rotating copper anode X-ray generator with Blue Confocal Osmic mirrors and a Rigaku 
Raxis IV
++
 detector. All data were integrated and scaled with HKL-2000 (63).  
Structure determination and refinement.  
The A467G, E89A,D,Q, and Ld_1,2,3g mutant enzyme structures were solved by the molecular 
replacement method using MOLREP (64) in the CCP4 package (65) and the previously solved 
rat cPEPCK structures of the same complexes (PDB ID: 3DT4, 3DT7 and 3DTB) (27). For each 
complex, the molecular replacement solution was refined using Refmac5 followed by manual 
model adjustment and rebuilding using COOT (66). Ligand, metal, water addition and validation 
were also performed in COOT. A final round TLS refinement was performed for all models in 
Refmac5. A total of 5 groups per chain for the A467G PEPCK-Mn
2+
-βSP-Mn
2+
GTP, A467G 
PEPCK-Mn
2+
-oxalate-Mn
2+
GTP, Ld_1g PEPCK-Mn
2+
-βSP-Mn
2+
GTP, Ld_1g PEPCK-Mn
2+
-
oxalate-Mn
2+
GTP, Ld_1g PEPCK-Mn
2+
-PEP-Mn
2+
GDP, Ld_2g PEPCK-Mn
2+
-βSP-Mn
2+
GTP, 
Ld_2g PEPCK-Mn
2+
-oxalate-Mn
2+
GTP, Ld_2g PEPCK-Mn
2+
-PEP-Mn
2+
GDP, Ld_3g PEPCK-
Mn
2+
-βSP-Mn
2+
GTP, Ld_3g PEPCK-Mn
2+
-oxalate-Mn
2+
GTP, Ld_3g PEPCK-Mn
2+
-PEP-
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Mn
2+
GDP, E89A PEPCK-Mn
2+
-βSP-Mn
2+
GTP, E89A PEPCK-Mn
2+
-oxalate-Mn
2+
GTP, E89A 
PEPCK-Mn
2+
-PGA-Mn
2+
GDP, E89D PEPCK-Mn
2+
-βSP-Mn
2+
GTP, E89D PEPCK-Mn
2+
-
oxalate-Mn
2+
GTP, E89D PEPCK-Mn
2+
-PGA-Mn
2+
GDP, E89Q PEPCK-Mn
2+
-βSP-Mn
2+
GTP, 
E89Q PEPCK-Mn
2+
-oxalate-Mn
2+
GTP, E89Q PEPCK-Mn
2+
-PGA-Mn
2+
GDP models were used 
as refinements using greater than five groups per chain did not significantly improve R/R free. A 
total of 20 groups per chain for the A467G PEPCK-Mn
2+
-PGA-Mn
2+
GDP model were used. The 
optimum TLS groups were determined by submission of the PDB files to the TLSMD server 
[http://skuld.bmsc.washington.edu/~tlsmd/] (67-69). 
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Appendices 
Appendix 1. Sequence alignment of 4 isoforms of PEPCK. 
The sequence alignment below is from four isoforms of PEPCK whose 3D structures have been 
solved; human and rat cytosolic PEPCK, chicken mitochondrial PEPCK, and E. Coli PEPCK. 
The sequence identity percentage is shown at the bottom. Active site residues and the Ω-loop lid 
are highlighted in blue. The RMSD calculation from the structures of each enzyme are at the 
bottom as well. 
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Appendix 2. PEPCK protein data bank entries 
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Appendix 3. All data with curve fits. 
WT rcPEPCK from the pGEX expression vector 
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A467G rcPEPCK from the pGEX expression vector 
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WT rcPEPCK from the pSUMO expression vector 
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E89A rcPEPCK from the pSUMO expression vector 
 
 
 
 
 126 
 
 
 
 
 127 
 
 
 
 
 128 
 
 
 
 
 129 
 
 
 
 
 130 
  
 131 
 
E89D rcPEPCK from the pSUMO expression vector 
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E89Q rcPEPCK from the pSUMO expression vector 
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Appendix 4. Crystallographic data and model statistics 
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